PROGRAMME

PROGRAMME
In combination with
Courses on Operative Andrology of the European School of Urology (ESU)
and
24. Jahrestagung der Deutschen gesellschaft für Andrologie (DgA)
28 november – 1 December 2012 • berlin (De)
www.andrology2012.de
NEW Journal
ANDROLOGY!
ANDROLOGY is the new merged Journal of the American Society
of Andrology and the European Academy of Andrology, incorporating
Journal of Andrology and International Journal of Andrology.
EDITORS:
Ewa Rajpert-De-Meyts and Douglas T Carrell
12 – 4 2 019
ANDROLOGY publishes basic, translational, clinical, and
epidemiological research in all areas of andrology.
Table of Contents
Organisation and Imprint ............................................................................................................................ 4
Welcome Note
of the Conference Chairs . ................................................................................................. 6
of the governing Mayor of Berlin .................................................................................... 7
Programme Overviews • 7th European Congress of Andrology . ......................................................... 8
Programmübersichten • Jahrestagung der DGA . ................................................................................... 11
Scientific Programme • 7th European Congress of Andrology
Wednesday, 28 November 2012 . ...................................................................................... 12
Thursday, 29 November 2012 ........................................................................................... 18
Friday, 30 November 2012 . ............................................................................................... 24
Wissenschaftliches Programm • Jahrestagung der DGA
Freitag, 30. November 2012 .............................................................................................. 29
Samstag, 1. Dezember 2012 .............................................................................................. 32
Poster Sessions .............................................................................................................................................. 34
Meeting Calendar .......................................................................................................................................... 54
Plan of Exhibition Area ................................................................................................................................ 55
Sponsors and Exhibitors .............................................................................................................................. 56
Media Cooperations ...................................................................................................................................... 57
Lunch Symposia . ........................................................................................................................................... 58
Social and Cultural Programme ................................................................................................................. 60
General Information . ................................................................................................................................... 63
Instructions for Speakers and Poster Presenters . ................................................................................... 69
Index of Authors and Chairs . ...................................................................................................................... 70
General Terms and Conditions ................................................................................................................... 78
City Map Berlin ............................................................................................................................................... 79
3
Organisation and Imprint
Venue
Seminaris CampusHotel Berlin
Science & Conference Center
Takustraße 39 • 14195 Berlin (DE)
Date
28 November–1 December 2012
Organiser
European Academy of Andrology (EAA)
EAU Section of Andrological Urology (ESAU)
German Society of Andrology (DGA)
Conference Chairs
Prof. Wolfgang Weidner
Justus-Liebig-University Gießen
Department of Urology, Pediatric Urology and
Andrology
Gießen (DE)
Prof. Andreas Meinhardt
Justus-Liebig-University Gießen
Department of Anatomy and Cell Biology
Gießen (DE)
Programme Organising Committee
Prof. Richard M. Sharpe (Chair)
University of Edinburgh
Medical Research Council
Centre for Reproductive Health
Edinburgh (GB)
Prof. Ewa Rajpert-De Meyts
Rigshospitalet
Copenhagen University Hospital
Department of Growth and Reproduction
Copenhagen (DK)
Prof. Vincenzo Mirone
University of Naples Federico II
Department of Gynecology, Urology and
Reproductive Medicine
Naples (IT)
Dr. Gert Dohle
Erasmus University Medical Centre
Department of Urology
Rotterdam (NL)
Prof. Nikolaos Sofikitis, MD
Ioannina University
Department of Urology
Ioannina (GR)
Dr. Serge Nef
Department of Genetic Medicine
and Development
University of Geneva Medical School
Geneva (CH)
Prof. Sabine Kliesch
University of Münster
Centre for Reproductive Medicine and Andrology
Münster (DE)
4
Organisation and Imprint
Prof. Stefan Schlatt
University of Münster
Centre for Reproductive Medicine and Andrology
Münster (DE)
Prof. Hermann M. Behre
University Hospital Halle (Saale)
Clinic for Reproductive Medicine and Andrology
Halle a. d. S. (DE)
Local organising committee – Justus-Liebig-University Gießen (DE)
Dr. Agnieszka Paradowska-Dogan
Prof. Hans-Christian Schuppe
Department of Urology, Pediatric Urology and
Department of Urology, Pediatric Urology and
Andrology
Andrology
Dr. Jörg Klug
Department of Anatomy and Cell Biology
Prof. Martin Bergmann
Department of Veterinarian Anatomy, Histology
and Embryology
Dr. Monika Fijak
Department of Anatomy and Cell Biology
Prof. Florian Wagenlehner
Department of Urology, Pediatric Urology and
Andrology
Conference Organisation
Conventus Congressmanagement & Marketing GmbH
Jana Radoi/Marit Herrnberger
Carl-Pulfrich-Straße 1 • 07745 Jena (DE)
Phone +49 (0)3641 311 63 62 • Fax +49 (0)3641 311 62 43
[email protected] • www.conventus.de
Conference Website
www.andrology2012.de
Design/Layout
Layout
Print
Circulation
Editorial Deadline
www.krea.tif–design.de
www.siblog.de
6.000
15 October 2012
The conference is supported by the German Research Foundation (DFG) and the B. Braun-Foundation.
5
Welcome Note of the Conference Chairs
Dear Friends and Colleagues
It is our pleasure to welcome you to the 7th European Congress of Andrology (ECA) to be held under
the auspices of the European Academy of Andrology (EAA), the EAU Section of Andrological Urology
(ESAU) and the German Society of Andrology (DGA) in Berlin from 28 November to 1 December, 2012.
We are delighted to announce that more than 250 abstracts were submitted, a record in the history
of the ECA, and would like to thank all authors for their active contribution allowing us to establish a
programme that covers all areas of andrology.
The 7th European Congress of Andrology will provide a forum for exchange among basic and clinical research in andrology, andrological urology, male reproductive biology and related fields. Active
participation is possible by a high number of short oral presentations and a poster session placed centrally in the programme.
The agreement on a joint teaching curriculum between the EAA and the ESAU has resulted in the idea of
also jointly organising the 7th European Congress of Andrology in conjunction with the DGA. In addition,
courses on andrological surgery co-ordinated by the European School of Urology will be held as part of
the congress. Thus, the congress offers an ideal opportunity for all andrological subspecialities to foster
broad exchange of ideas and collaborations.
The 7th ECA will be held in the Seminaris CampusHotel Berlin, a brand new glass cube, recently voted
amongst the best congress settings in Germany.
Few cities have experienced as many changes over recent years as Berlin being transformed from two
separate entities into one again. The city is not only renowned for its architectural monuments and
museums, it also offers green oases and night life galore. Often, only a short walk separates elegant
boulevards and Berlin’s more alternative neighbourhoods which altogether add to its reputation as one
of Europe’s most exciting cities.
We look forward to welcoming you in Berlin!
Yours
Wolfgang Weidner
Andreas Meinhardt
Justus-Liebig-University Gießen
Justus-Liebig-University Gießen
Department of Urology,
Department of Anatomy and Cell Biology
Pediatric Urology and Andrology
6
Welcome Note of the GOVERNING Mayor of Berlin
Dear Participants
I would like to welcome all of the participants in the 7th European Congress of Andrology to Berlin.
I am delighted that you have chosen Germany’s capital city as the venue for this important congress.
Andrology’s significance as a medical specialty has been growing for years now. Many men are banking
on scientific research and medical advances that will lead to better diagnostic techniques and new
options for treatment. One of the German Society for Andrology’s key goals is to ensure that andrological expertise is better represented in all areas of medicine and the natural sciences and to thereby
promote interdisciplinary cooperation. I hope that the European Congress of Andrology will help to
sharpen awareness of potential synergies between the various specialties and to pave the way for more
cooperation outside the boundaries of one’s own field.
It is a great honour for Berlin to be hosting the European Congress of Andrology this year. As a renowned
scientific and academic location and a center of cutting-edge life sciences research, as well as one of
the world’s most popular conference venues, Germany’s capital offers ideal conditions for a successful
congress.
In this spirit, I would like to welcome you once again to Berlin and to wish you thought-provoking professional exchange and, for our visitors from outside the city, an enjoyable and inspiring stay.
Klaus Wowereit
Governing Mayor of Berlin
7
Programme Overviews • 7th European Congress of Andrology
Wednesday, 28 November 2012
Variabilis
08:30
08:45
09:00
09:15
09:30
09:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
18:15
18:30
18:45
19:00
19:15
19:30
19:45
20:00
8
Harvard
Stanford
Princeton
Welcome
ECA Opening Lecture
p. 12
Break
Short Oral Presentations:
Session 1
Free Communications,
New Horizons in Andrology
p. 12
Welcome Reception
p. 16
Short Oral Presentations:
Session 2
Hypogonadism, Metabolic
Syndrome and Reproductive Function
Short Oral Presentations:
Session 3
Sexual Dysfunction, Sexual
Medicine & Andrological
Implications of Genital
p. 13 Tract Infections
p. 14
Short Oral Presentations:
Session 4
Sperm Quality and Selection
for ART, Determinants of
Male Reproductive Health, Genetics and Epigenetics p. 16
Programme Overviews • 7th European Congress of Andrology
Thursday, 29 November 2012
08:30
08:45
09:00
09:15
09:30
09:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
18:15
18:30
18:45
19:00
19:15
19:30
19:45
20:15
Variabilis
ECA Plenary Lecture 1
Metabolic Syndrome and
Reproductive Function
Harvard
Princeton
ESU Course 1
Priapism, Penile Implants &
Reconstruction and other
Surgical Problems in ED
p. 18
Break
Poster Sessions
p. 18
p. 18
Lunch Break
ECA Plenary Lecture 2
Ageing
ESU Course 2
Peyronie‘s Disease
p. 20
p. 20
Break
Break
ECA Session 2
Epigenetic Mechanisms and
Small RNAs
ECA Session 1
Developmental Determinants
in Male Reproductive Health
p. 21
p. 21
p. 22
Break
ECA Session 3
Sexual Dysfunction and
Erectile Failure
ECA Session 4
Pick One and Inject – Will any
Old Sperm do for ART?
p. 23
Conference Dinner
ESU Course 3
Varicocele
p. 23
p. 60
9
Programme Overviews • 7th European Congress of Andrology
Friday, 30 November 2012
Variabilis
08:30
08:45
09:00
09:15
09:30
09:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
18:15
18:30
18:45
19:00
19:15
19:30
19:45
20:00
10
Harvard
Princeton
ECA Plenary
Lecture 3
Non-Obstructive Azoospermia
p. 24
Break
ECA Session 5
Klinefelter‘s Syndrome
ECA Session 6
Andrological Implications of
Genital Tract Infections
ESU Course 4
Obstruction of the Seminal
Pathways
p. 24
p. 24
p. 25
Lunch Break
ECA Session 7
ECA Session 8
Normal and Abnormal Development Testicular Cancer
of the Male Reproductive Tract
p. 25
ESU Course 5
Sperm Retrieval
p. 26
p. 26
Break
ECA Session 9
INYR Session: Genetics of Male
Infertility
ESU Course 6
Vasectomy, Sperm Retrieval and
Spermatic Cord Denervation
p. 27
Break
ECA Plenary
Lecture 4
New Horizons in Andrology
Farewell
p. 28
p. 28
p. 27
Programmübersichten • Jahrestagung der DGA
Freitag, 30. November 2012
08:30
08:45
09:00
09:15
09:30
09:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
18:15
18:30
18:45
19:00
19:15
19:30
19:45
20:00
Stanford
Forum Junge Andrologie
Testosteron und Psyche
S. 29
Pause
Workshop
Ejakulatanalyse nach WHO-Empfehlungen
S. 29
Pause
Lunchsymposium
Fresenius Kabi Deutschland GmbH
S. 30
pause
Workshop
Imaging & Histologie in der Uro-Andrologie:
Pflicht oder Kür?
S. 30
Pause
Seminar des Arbeitskreises Andrologie
der DGU
Teil 1
S. 30
Pause
Seminar des Arbeitskreises Andrologie
der DGU
Teil 2
S. 31
Mitgliederversammlung DGA
S. 31
Samstag, 1. Dezember 2012
08:30
08:45
09:00
09:15
09:30
09:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
18:15
18:30
18:45
19:00
19:15
19:30
19:45
20:00
Stanford
Neues in der Andrologie:
State of the Art
Teil 1
S. 32
Pause
Neues in der Andrologie:
State of the Art
Teil 2
S. 32
Pause
Lunchsymposium
Jenapharm
S. 33
Pause
Neues in der Andrologie:
State of the Art
Teil 3
Verabschiedung
S. 33
S. 33
11
Scientific Programme • Wednesday, 28 November 2012 • 7th European Congress of Andrology
1600–1615
Room Variabilis
Welcome
W. Weidner, A. Meinhardt (Gießen/DE), R. M. Sharpe (Edinburgh/GB)
1615–1700
ECA Opening Lecture
Room Variabilis
Chair
R. M. Sharpe (Edinburgh/GB)
1615
ID 1
What makes a normal man?
J. Toppari (Turku/FI)
1700–1715Break
1715–1845 Short Oral Presentations – Session 1:
Room VariabilisFree Communications, New Horizons in Andrology
Chairs
S. Schlatt (Münster/DE), K. Kula (Lodz/PL)
1715
Compartmentalization and regulation of iron metabolism proteins protect male germ
ID 2
cells from peripheral iron fluctuation
E. Meyron-Holtz (Haifa/IL)
1725
ID 20
Epigenetic biomarkers of testis and epididymis existing in extracellular nucleic acids
from human semen
H. Li (Wuhan/CN)
Worsening inhibin B, but not testosterone, secretion after kidney transplantation in
1735 ID 4
male patients under 45 years
S. Hamdi (Toulouse/FR)
1745
ID 6
Detection of polysialylated NCAM on mammalian sperms
S. P. Galuska (Gießen/DE)
1755
Insulin-like factor 3 (INSL3) – a new clinical parameter for andrology
ID 7 R. Anand-Ivell (Dummerstorf/DE)
1805
Membrane transporters for sulfated steroids and steroid sulfatase expression in the
ID 8
human testis – a functional system?
D. Fietz (Gießen/DE)
1815
Combined effects of the variants FSHB-211G/T and FSHR2039A>G on male
ID 9 reproductive parameters
F. Tüttelmann (Münster/DE)
12
Scientific Programme • Wednesday, 28 November 2012 • 7th European Congress of Andrology
1825
ID 10
Accumulation of chymase-positive testicular mast cells in infertility patients and
evidence for local angiotensin II effects
H. Welter (Munich/DE)
1835 Discussion
1715–1845 Short Oral Presentations – Session 2:
Hypogonadism, Metabolic Syndrome and Reproductive Function
D. Goulis (Thessaloniki/GR), H. M. Behre (Halle a. d. S./DE)
Room Harvard Chairs
1715
Sustained improvement of features of the metabolic syndrome upon normalisation
ID 11
of serum testosterone in hypogonadal men – follow-up up to 5 years
A. Haider (Bremerhaven/DE)
1725
ID 12
Hypogonadism as a risk factor for cardiovascular mortality in men – a meta-analytic
study
G. Rastrelli (Florence/IT)
1735
ID 13
Body mass index regulates hypogonadism-associated cardiovascular risk – results froms
a cohort of subjects with erectile dysfunction
G. Corona (Florence/IT)
1745
ID 14 Obesity, insulin resistance and their correlation with testosterone level in caucasian
male patients
S. Janjgava (Tbilisi/GE)
1755
ID 15
Insulin resistance is associated with increased seminal plasma insulin concentrations
and reduced semen parameters in obese patients
K. Leisegang (Bellville/ZA)
1805
ID 16
Impact of metabolic syndrome on male fertility parameters
A. Pilatz (Gießen/DE)
1815
Testosterone protects from metabolic syndrome-associated prostate inflammation:
ID 17
an experimental study in rabbits
L. Vignozzi (Florence/IT)
13
Scientific Programme • Wednesday, 28 November 2012 • 7th European Congress of Andrology
1825
ID 18
Negative association between levels of testosterone and inflammatory markers in
young men
J. Bobjer (Malmö/SE)
1835 Discussion
1715–1845 Short Oral Presentations – Session 3:
Sexual Dysfunction, Sexual Medicine & Andrological Implications of Genital
Tract Infections
ChairsF. Ochsendorf (Frankfurt a. M./DE), E. A. Jannini (Florence/IT)
Room Stanford
1715
ID 21
Alpha-haemolytic strains of uropathogenic E.coli prematurely activate the acrosome
reaction and induce DNA damage in sperm
T. Lang (Gießen/DE)
1725
ID 22
The value of prostate biopsy in diagnosis of urotuberculosis
E. Kulchavenya (Novosibirsk/RU)
1735
ID 23
Bacteria and leukocytes as inducers of molecular changes in human-ejaculated sperm
plasma membranes during in vitro semen infection
M. Fraczek (Poznan/PL)
1745
ID 24
The global online sexuality survey – sexual function and dysfunction in USA
O. Shaeer (Cairo/EG)
1755
ID 25
Associations between asymptomatic prostatitis and erectile dysfunction in ageing male
K. Ausmees (Tartu/EST)
1805
ID 26 Body height and sexual activity – Hungarian data
I. Rurik (Debrecen/HU)
1815
ID 27
The SIAMS-ED study – a spontaneous, multicentre, observational study on the efficacy
of vardenafil in men with erectile dysfunction and cardiovascular risk factors
A. M. Isidori (Rome/IT)
1825
Clinical correlates of erectile dysfunction and premature ejaculation in men with couple
ID 28
infertility
F. Lotti (Florence/IT)
1835 14
Discussion
www.andrologen.info
andrologen.info
Zeitschrift für Urologie und Andrologie
10. Jahrgang • 2012
Andrologie • Urologie • Uro-Onkologie
Verlag: pro anima medizin medien • Amselstr. 18 • 45472 Mülheim a.d. Ruhr
Tel.: 0208 3056-166 • Fax: 0208 3056-167 • [email protected]
Anzeige_AI_Juni.indd
53
13.07.2012, 10:03
Scientific Programme • Wednesday, 28 November 2012 • 7th European Congress of Andrology
1715–1845 Short Oral Presentations – Session 4:
Sperm Quality and Selection for ART, Determinants of Male Reproductive Health,
Genetics and Epigenetics
Chairs
R. Henkel (Bellville/ZA), K. Steger (Gießen/DE)
Room Princeton
1715
ID 29
Long-term contraception with risug and its functional reversal by DMSO and
NaHCO3 in rats
A. S. Ansari (Jaipur/IN)
1725
Deficient testosterone production during the masculinization programming window
ID 30
is associated with Sertoli-cell only tubules and focal dysgenesis in adulthood
S. van den Driesche (Edinburgh/GB)
1735
ID 31
Impact of the selenoprotein nGPx4 on male fertility and sperm epigenome
C. Boitani (Rome/IT)
1745
Correlation between spermatozoal DNA integrity (TUNEL assay) and chromatin
ID 32
condensation (GRAM staining) with basic semen analysis in subfertile men and normal
controls
L. Karamountzos (Athens/GR)
1755
ID 33 The methylation analysis of histone H4K12ac associated promoters in sperm of healthy
donors and subfertile patients
A. Paradowska-Dogan (Gießen/DE)
Even globozoospermic spermatozoa have cephalic vacuoles
1805
ID 34 N. Gatimel (Toulouse/FR)
1815
ID 35
Epimutations in RHOX genes are associated with male infertility
M. E. Richardson (San Diego, CA/US)
1825
Reference values of sperm chromatin dispersion test in sperm donors with known
ID 36
fecundity
S. Camarena (Barcelona/ES)
1835
ID 37 UVB-induced mitochondrial dysfunction does not correlate with sperm DNA
fragmentation
V. Sanchez (Münster/DE)
1900
Welcome Reception (see page 60)
16
Anzeige Meda
EVERY MAN
HAS THE RIGHT
Erektion auf natürlichem Wege
Schnell und zuverlässig in der Wirkung bei ED verschiedenster Ursache1,2
Bessere Verträglichkeit und Akzeptanz im Vergleich zur Injektion2,3
Hohe Ansprechrate in Kombination mit PDE5-Hemmern4
MUSE® 250 / 500 / 1000 Mikrogramm.Wirkstoff: Alprostadil. Zusammensetzung: 1 steriler Einmalapplikator enth. 250 μg/500 μg/1000 μg Alprostadil. Sonst. Bestandteil: Macrogol 1450. Darreichungsform und Inhalt: Stäbchen zur Anwend.
in der Harnröhre. MUSE® ist ein steriles transurethrales Einmalsystem zurVerabreichung von Alprostadil in die männliche Harnröhre. Das in der Spitze des Polypropylenapplikators enthaltene Stäbchen zur Anwend. in der Harnröhre (1,4 mm
Durchmesser, Länge 3 oder 6 mm) enth. Alprostadil suspendiert in Macrogol. Anwendungsgebiete: Behandl. der primär organisch bedingten Erektilen Dysfunktion; Hilfsmittel für den Test zur Diagnose u. Behandl. der Erektilen Dysfunktion. Gegenanzeigen: Überempfindlichkeit gegen Alprostadil od. einem der sonst. Bestandteile, anormale Penisanatomie (Harnröhrenstriktur, schwere Hypospadie, starke Krümmung), Balanitis, akute/chronische Urethritis, erhöhtes
Priapismus-Risiko (Sichelzellenanämie, entsprechende Erbanlage,Thrombozythämie, Polyzythämie, multiples Myelom, Neigung zuVenenthrombosen, Priapismus in der Anamnese), instabiler kardiovaskulärer/zerebrovaskulärer Zustand.
Nicht zur Anwendung bei Frauen u. Kindern. Nebenwirkungen: Sehr häufig: Brennen in der Harnröhre, Penisschmerz. Häufig: Hodenschmerz, Brennen/Jucken in der Scheide (b. d. Partnerin), geringe Harnröhrenblutung, Kopfschmerzen,
Schwindelgefühl, symptomatische Hypotonie. Gelegentlich: Synkope, geschwollene Beine, Schmerz in den Beinen, Schmerz im Bereich des Perineums, schneller Puls. Selten: Harnwegsinfektionen, verlängerte Erektionen/Priapismus,
Erkrankungen des Penis (z.B. fibrotische Komplikationen). Sehr selten: Exantheme, Urtikaria. Hinweis: Bei bestehender/möglicher Schwangerschaft der Partnerin muss ein Kondom benutzt werden. Bei gleichzeitiger Antikoagulanzientherapie od. Gerinnungsstörung Risiko einer Harnröhrenblutung erhöht. Nach Verabreichung sollte der Patient wegen eines möglichen Blutdruckabfalls nicht Auto fahren od. riskante Aufgaben mit Verletzungsgefahr durchführen. Weitere
Einzelheiten und Hinweise: s. Fach- und Gebrauchsinformation. Verschreibungspflichtig. Stand: Februar 2010. Pharmazeutischer Unternehmer: MEDA Pharma GmbH & Co. KG, Benzstraße 1, 61352 Bad Homburg, www.medapharma.de
1 Fachinformation MUSE® | 2 Padma-Nathan H, et al. Treatment of men with Erectile Dysfunction with transurethral alprostadil; N Engl J Med 1997;336:1-7. | 3 Potempa AJ, Potempa DM, Görlich HD, et al. Intraurethral zu applizierendes
Alprostadil zur Behandlung der primär organisch bedingten Erektilen Dysfunktion in der Praxis / Multizentrische klinische Beobachtungsstudie (nicht-interventionelle Untersuchung). Arzneimittelforschung 2007;57(6):299-308. | 4
Nehra A. Oral and Non-Oral Combination Therapy for Erectile Dysfunction. Rev Urol. 2007; 9(3):99-105.
Scientific Programme • Thursday, 29 November 2012 • 7th European Congress of Andrology
0830–1000 ECA Plenary Lecture 1 • Metabolic Syndrome and Reproductive Function
Room Variabilis
ChairsF. Wu (Manchester/GB), A. Giwercman (Malmö/SE)
0830
ID 38
Special Lecture of the International Journal of Andrology
Effects of metabolic syndrome on the male reproductive system
M. Maggi (Florence/IT)
0910
ID 39
Testosterone and cardiovascular health
K. Channer (Sheffield/GB)
0935
ID 40
Metabolic syndrome and reproductive function
A. Salonia (Milan/IT)
1000–1015 Break
1015–1215
Poster Sessions (see page 34)
0830–1045 Chair
ESU Course 1 • Priapism, Penile Implants & Reconstruction
and other Surgical Problems in ED V. Mirone (Naples/IT)
Surgical Andrology – Introductory Remarks
W. Weidner (Gießen/DE)
0830
Priapism
D. J. Ralph (London/GB)
Room Princeton
0845
Penile implants
E. J. H. Meuleman (Amsterdam/NL)
0900
Trouble shooting in penile implant surgery
C. Bettocchi (Bari/IT)
0915
Phalloplasties
M. Sohn (Frankfurt a. M./DE)
0930
ID 41 Supersizing the penis following penile prosthesis implantation
O. Shaeer (Cairo/EG)
0940
Assessment of erectile function after surgical treatment of penile fracture
ID 42 O. Zhukov (Moscow/RU)
18
Scientific Programme • Thursday, 29 November 2012 • 7th European Congress of Andrology
0950
ID 43
Sexual dysfunction after surgical treatment of benign prostatic hyperplasia
M. Alchinbayev (Almaty/KZ)
1000
ID 44
Erectile function after robot-assisted laparoscopic radical prostatectomy with complete
excision of the neurovascular bundles – are all patients later on impotent?
A. Abdulhak (Gronau/DE)
1010
ID 45 Impact of circumcision on the sexual function of patients with phimosis
J. Dias (Vila Nova de Gaia/PT)
1020
ID 46
Erectile function improvement with oral sildenafil versus placebo in posterior
urethroplasty – double blind randomized controlled trial
A. Moeini (Tehran/IR)
1030
ID 47 The impact of ventral oral graft bulbar urethroplasty on the ejaculatory function,
erectile function and sexual life
E. Palminteri (Arezzo/IT)
1040
Discussion
1215–1330 Lunch Break
19
Scientific Programme • Thursday, 29 November 2012 • 7th European Congress of Andrology
1330–1500 ECA Plenary Lecture 2 • Ageing
Room Variabilis
Chairs
D. A. Adamopoulos (Athens/GR), I. T. Huhtaniemi (London/GB, Turku/FI)
1330
The ageing testis
ID 48B. Robaire (Montreal/CA)
1400Genetic changes in spermatogonia of older man
ID 49A. Wilkie (Oxford/GB)
1430
The natural history of late onset hypogonadism – implications for clinical
ID 50
management
F. Wu (Manchester/GB)
1330–1500 ESU Course 2 • Peyronie’s Disease Room Princeton
Chair W. Weidner (Gießen/DE)
1330Guidelines on surgical therapy
M. Sohn (Frankfurt a. M./DE)
1345Surgical therapy of Peyronie’s disease
A. Kadioglu (Istanbul/TR)
Additional ESWT
1400
F. Fusco (Naples/IT)
1415Surgical treatment methods of Peyronie’s disease
ID 51
S. Gamidov (Moscow/RU)
1425
ID 52
Dynamic contrast-enhanced MRI of the penis in tumescence before surgical treatment
of Peyronie’s disease – preliminary results
C. M. Woitzik (Gießen/DE)
1435
ID 53 Surgical treatment of penile curvature with the tunica albuginea underlap technique:
description of the technique and clinical results
H. Steinfatt (Munich/DE)
1445
ID 54
Radiotherapy is safe, clinically effective and well accepted by patients with Morbus
Peyronie
J. Gutermuth (Munich/DE)
1455
Discussion
20
Scientific Programme • Thursday, 29 November 2012 • 7th European Congress of Andrology
1500–1530 Break
1530–1700 ECA Session 1 • Developmental Determinants in Male Reproductive Health
Room Variabilis
ChairsN. E. Skakkebæk (Copenhagen/DK), J. E. Bustos-Obregon (Santiago/CL)
1530
ID 55 Prenatal determinants of adult male reproductive health
M. L. Eisenberg (Stanford, CA/US)
1600
ID 56
Modifying effects of prenatal and postnatal lifestyle on semen quality and fertility
T. Kold Jensen (Odense/DK)
1630
ID 57
In vivo effects of Eurycoma longifolia (tongkat ali) extract on reproductive functions in
the rat
R. Henkel (Bellville/ZA)
1645
Why androgen based male hormonal contraception lacks efficacy – evidence from a
ID 58 mouse model
O. O. Oduwole (London/GB)
1530–1700 ECA Session 2 • Epigenetic Mechanisms and Small RNAs
Room Harvard
Chairs
D. Miller (Leeds/GB), D. T. Carrell (Salt Lake City, UT/US)
1530Roles of small noncoding RNAs in male reproduction
ID 59
W. Yan (Reno, NV/US)
1600
Post-meiotic male genome reprogramming
ID 60S. Rousseaux (La Tronche, Grenoble/FR)
1630
ID 61
UBE2B messenger RNA mutations are associated with severe oligozoospermia in
infertile men
A. Yatsenko (Pittsburgh, PA/US)
1645
ID 62 Differential proteomic distribution in the chromatin of human sperm cells
J. Castillo (Barcelona/ES)
1700–1715Break
21
Scientific Programme • Thursday, 29 November 2012 • 7th European Congress of Andrology
1530–1715 ESU Course 3 • Varicocele
Room Princeton
Chair
G. Dohle (Rotterdam/NL)
1530
Varicocele in infertility
T. Diemer (Gießen/DE)
1545
Microsurgical dissection
A. Jungwirth (Salzburg/AT)
1600
Varicocele in adolescent
R. Kocvara (Prague/CZ)
1615
Other therapy (e. g. embolisation)
C. Bettocchi (Bari/IT)
1630
ID 63
Surgical subinguinal approach to varicocele combined with antegrade intraoperative
sclerosis of venous vessels
G. Bozzini (Milan/IT)
1640Low ligation with oral treatment improves spermogram in infertile men
ID 64 B. Elteer (Tripolis/LY)
1650
Antegrade scrotal sclerotherapy for the treatment of varicocele in adults, childhood
ID 65 and adolescence
R. Tauber (Hamburg/DE)
Color doppler evaluation of spermatic vein reflux predicts sperm quality improvement
1700
ID 66 following varicocelectomy
F. Pelliccione (Milan/IT)
1710
22
Discussion
Scientific Programme • Thursday, 29 November 2012 • 7th European Congress of Andrology
1715–1845 ECA Session 3 • Sexual Dysfunction and Erectile Failure
Room Variabilis
ChairsE. Wespes (Brussels/BE), G. Corona (Florence/IT)
1715
Sexual dysfunction and erectile failure – new aspects from the urological
ID 67 point of view
E. Wespes (Brussels/BE)
1745
ID 68
Sexual dysfunction and erectile failure – new aspects from the andrological
point of view
A. Isidori (Rome/IT)
1815
ID 69
Efficacy of PSD502 (TEMPE) is similar in lifelong and acquired premature ejaculation on
initial dosing and in the long term
M. Wyllie (Borden/GB)
1830
ID 70 Sexual dysfunctions induced by stress of timed intercourse and medical treatment
C. Bak (Seoul/KR)
1715–1845 ECA Session 4 • Pick One and Inject – Will any Old Sperm do for ART?
Room Harvard Chairs S. Francavilla (L’Aquila/IT), H.-C. Schuppe (Gießen/DE)
1715
ID 71 Current status and unresolved issues in ICSI
H. Tournaye (Brussels/BE)
Sperm biology functions tests in relation to ART (assisted reproduction techniques)
1740
ID 72 E. Baldi (Florence/IT)
1805
ID 73 In vivo monitoring techniques to select the best sperm for ICSI
C. Mallidis (Münster/DE)
1830
ID 74 The impact of RNA expression in human spermatozoa on male fertility
H. Cappallo-Obermann (Hamburg/DE)
2015 Conference Dinner (see page 60)
23
Scientific Programme • Friday, 30 November 2012 • 7th European Congress of Andrology
0900–1000 Room Variabilis
ECA Plenary Lecture 3 • Non-Obstructive Azoospermia
ChairsA. Jungwirth (Salzburg/AT), M. Marconi (Santiago/CL)
0900
Non-obstructive azoospermia
ID 75 S. Minhas (London/GB)
0930
ID 76
Exchange Lecture of the European Academy of Andrology and American Society
of Andrology
Imaging of the male genital tract – from ultrasound to MRI and beyond
P. Turek (San Francisco, CA/US)
1000–1030 Break
1030–1145 ECA Session 5 • Klinefelter´s Syndrome
Chairs
G. Forti (Florence/IT), J. Slowikowska-Hilczer (Lodz/PL)
1030
ID 77
The Münster EXAKT project – the epi-genetic phenotype of XXY
J. Gromoll (Münster/DE)
1100
ID 78
Klinefelter´s syndrome – an update
A. Juul (Copenhagen/DK)
1130
ID 79 Number and protein expression of Sertoli cells is altered in 41,XXY* mice, an animal
model of Klinefelter´s syndrome
J. Wistuba (Münster/DE)
1030–1200 ECA Session 6 • Andrological Implications of Genital Tract Infections
Chairs
F. Francavilla (L’Aquila/IT), M. Kurpisz (Poznan/PL)
Room Variabilis
Room Harvard
1030Regulatory T cells control post-vasectomy response
ID 80
K. Tung (Charlottesville, VA/US)
1100
Prostatitis and andrological implications
ID 81F. Wagenlehner (Gießen/DE)
1130
HMGB1 modulates immune responses in a cell-specific manner in the rat autoimmune
ID 82 orchitis
F. Aslani (Gießen/DE)
1145
Protective effect of probiotic lactobacilli against sperm damage exerted by soluble
ID 83 factors from Escherichia coli – focus on lipopolysaccharide
A. Barbonetti (L´Aquila/IT)
24
Scientific Programme • Friday, 30 November 2012 • 7th European Congress of Andrology
1030–1215 ESU Course 4 • Obstruction of the Seminal Pathways Room Princeton
Chair
Z. Kopa (Budapest/HU)
1030General considerations
J. U. Schwarzer (Munich/DE)
1045
Vasovasostomy
H. Sperling (Mönchengladbach/DE)
1100
Tubulovasostomy
G. Dohle (Rotterdam/NL)
1115
TURED, seminal vesicle puncture and wash-out
G. M. Colpi (Milan/IT)
1130
Ultrasonographic determination of caput epididymidis diameter is strongly
ID 84 predictive of obstruction in the genital tract in azoospermic men with normal
serum FSH
A. Pezzella (L’Aquila/IT)
1140
ID 85 Vasoscopy – a new diagnostic and therapeutic tool in andrology?
M. Trottmann (Munich/DE)
1150
ID 86 Seminal plasma biomarkers and congenital bilateral absence of the vas deferens:
relationships with the anatomical urogenital phenotypes and place in the diagnostic
strategy
C. Teston (Toulouse/FR)
1200
Male infertility – a rare complex case of abnormal development of the seminal
ID 87
pathways
R. Amorim (Vila Nova de Gaia/PT)
1210
Discussion
1215–1330
Lunch Break
1330–1430 ECA Session 7 • Normal and Abnormal Development of the Male Reproductive Tract
Room Variabilis
Chairs
J. Toppari (Turku/FI), M. L. Eisenberg (Stanford, CA/US)
1330 ID 88
Cryptorchidism – clinical perspective
O. Söder (Stockholm/SE)
25
Scientific Programme • Friday, 30 November 2012 • 7th European Congress of Andrology
1400
Delayed puberty
ID 89N. Pitteloud (Lausanne/CH)
1330–1500 ECA Session 8 • Testicular Cancer
Room Harvard
ChairsE. Rajpert-De Meyts (Copenhagen/DK), T. B. Haugen (Oslo/NO)
1330
Models of testicular cancer
ID 90 L. Looijenga (Rotterdam/NL)
1400
ID 91
Non-invasive diagnosis of testicular carcinoma in situ in ejaculates – perspectives in
relation to current routine methods
K. Almstrup (Copenhagen/DK)
1430Long-term follow up using testicular sparing surgery for Leydig cell tumor
ID 92 G. Bozzini (Milan/IT)
1445
ID 93 Is preservation of dysgenetic gonads until adulthood justified?
J. Slowikowska-Hilczer (Lodz/PL)
1330–1500 ESU Course 5 • Sperm Retrieval
Room Princeton
Chair N. Sofikitis (Ioannina/GR)
1330General considerations
ID 94S. Minhas (London/GB)
1345
TESE and M-TESE
T. Diemer (Gießen/DE)
1400
MESA and ductus aspiration
Z. Kopa (Budapest/HU)
1415Results of a combined trifocal TESE plus M-TESE in a series of 75 “low chance” nonID 95
obstructive azoospermia (NOA) patients – experience from 2 centers
M. Marconi (Santiago/CL)
1425
ID 96
Multimodal MRI of the testes for characterisation of intact spermatogenesis in nonobstructive azoospermia – a pilot study for establishing functional MRI of the testes
S. Irrle (Gießen/DE)
1435
ID 97 What predicts the success of sperm retrieval in adolescents with Klinefelter´s syndrome?
J. Rohayem (Münster/DE)
26
Scientific Programme • Friday, 30 November 2012 • 7th European Congress of Andrology
1445
ID 98
Outcome of microdissection testicular sperm extraction in patients with non-mosaic
Klinefelter´s syndrome
M. A. Sadighi Gilani (Tehran/IR)
1455
Discussion
1500–1530Break
1530–1700
ECA Session 9 • INYR Session: Genetics of Male Infertility
Room Variabilis
ChairsF. Tüttelmann (Münster/DE), J. B. Stukenborg (Stockholm/SE)
1530
ID 99
Sex chromosome linked genetic factors in male infertility
C. G. Krausz (Florence/IT)
1600
Potential biomarkers of non-obstructive azoospermia indentified in gene expression
ID 100
analysis
A. Waclawska (Poznan/PL)
1615
Human sperm tail proteomics – new insights on endogenous metabolic pathways
ID 101A. Amaral (Barcelona/SP)
1630
A genome-wide DNA methylation study in azoospermia
ID 102F. Ferfouri (Versailles/FR)
1645
ID 103 New insights into sperm DNA methylation – intra- and inter individual stability and
the methylation status of piRNA genes
C. Chianese (Florence/IT)
1530–1700 Chair ESU Course 6 • Vasectomy, Sperm Retrieval and Spermatic
Cord Denervation
A. Jungwirth (Salzburg/AT)
1530
The new EAU and AUA guidelines
G. Dohle (Rotterdam/NL)
1545
Non scalpel-vasectomy
W. Aulitzky (Vienna/AT)
1600
ID 104 Microsurgical spermatic cord denervation for chronic testicular pain
M. Marconi (Santiago/CL)
Room Princeton 27
Scientific Programme • Friday, 30 November 2012 • 7th European Congress of Andrology
1610
ID 105
Micro-TESE option in NOA management
D. Palanisamy (Kodungalore/IN)
1620
ID 106
Probe–based confocal laser endomicroscopy (pCLE) – a new diagnostic tool in
andrology
S. Koelle (Munich/DE)
1630
ICSI from “fresh” TESE in absolute asthenozoospermia – an option or the solution?
ID 107F. M. Castiglioni (Milan/IT)
1640
Is it worth doing spermatozoa retrieval in azoospermic non-mosaic Klinefelter´s
ID 108
syndrome patients?
R. Amorim (Vila Nova de Gaia/PT)
1650
Discussion
1700–1715Break
1715–1815 ECA Plenary Lecture 4 • New Horizons in Andrology
Room Variabilis
Chairs
S. Nef (Genf/CH), R. Anand-Ivell (Dummerstorf/DE)
1715Genetic models of the future – making the most of the available technology
ID 109L. Smith (Edinburgh/GB)
1745
ID 110
Sperm chemotaxis
I. Weyand (Jülich/DE)
1815
Farewell
W. Weidner, A. Meinhardt (Gießen/DE)
Room Variabilis
28
Wissenschaftliches Programm • Freitag, 30. November 2012 • Jahrestagung der DGA
0830–0930 Forum Junge Andrologie – Testosteron und Psyche
Raum Stanford
Vorsitz
J. Maliske, S. Schlatt (Münster/DE)
0830
Wie beeinflusst Testosteron Mann in seinem Denken und Handeln? – Mythos und Wahrheit
A. Meißner (Amsterdam/NL)
0900Einfluss von Sexualsteroiden auf das Kurz- und Langzeitgedächtnis mittels funktioneller
MR-Bildgebung (fMRT)
Y. Morikawa (Münster/DE)
0930–1000 Pause
1000–1200 Workshop – Ejakulatanalyse nach WHO-Empfehlungen
Raum Stanford
VorsitzF. Ochsendorf (Frankfurt a. M./DE), G. Haidl (Bonn/DE)
1200–1330 Pause
Intensivkurs 2013
der Deutschen Gesellschaft für Andrologie
Stuttgart
1. und 2. Februar 2013
Steigenberger Graf Zeppelin Hotel
Information und Registrierung unter: www.dga-intensivkurs.de
29
Wissenschaftliches Programm • freitag, 30. november 2012 • Jahrestagung der DGa
1215–1315
raum Stanford
Vorsitz
lunchsymposium fresenius Kabi Deutschland GmbH
ANNA C-TrUS – artifizielle neuronale Netzwerk-Analyse
J. C. Walz (Marseille/fR)
1215
“anna C-TRUs” stellenwert in der literatur
f. Wagenlehner (Gießen/De)
1245
Externe Validierung des “ANNA C-TrUS” Sytems
J. C. Walz (Marseille/fR)
1330–1430
Workshop – Imaging & Histologie in der Uro-Andrologie – Pflicht oder Kür?
raum Stanford
Vorsitz
J. C. Walz (Marseille/fR), W. schulze (Hamburg/De)
1330
Sonographie der genitalorgane
C. leiber (freiburg i. br./De), a. Pilatz (Gießen/De)
1400
Histologie des Hodens
M. bergmann, H.-C. schuppe (Gießen/De)
1430–1500
Pause
1500–1630
Seminar des Arbeitskreises Andrologie der
Deutschen gesellschaft für Urologie – Teil 1
(mit freundlicher Unterstützung der lilly Deutschland GmbH)
s. Kliesch (Münster/De), G. Popken (berlin/De)
raum Stanford
Vorsitz
1500
Testosteron und Prostatakarzinom
H. Sperling (Mönchengladbach/DE)
1530
Testosteron – Haut und Haare
f.-M. Köhn (München/De)
1600
Testosteron und sexualität
T. Diemer (gießen/DE)
1630–1645
Pause
30
Wissenschaftliches Programm • Freitag, 30. November 2012 • Jahrestagung der DGA
1645–1815 Vorsitz
Seminar des Arbeitskreises Andrologie der
Deutschen Gesellschaft für Urologie – Teil 2
(mit freundlicher Unterstützung der Lilly Deutschland GmbH)
I. Schröder-Printzen (Gießen/DE), C. Leiber (Freiburg i. Br./DE)
1645
Testosteron und Herz
J. vom Dahl (Mönchengladbach/DE)
Raum Stanford
1715
Testosteron und Genetik
F. Tüttelmann (Münster/DE)
1745Geschichte des Testosterons
D. Schultheiss (Gießen/DE)
1830–1930
Mitgliederversammlung DGA
Raum Stanford
• Relief and support to organizing/
scientific committees
• Professionalism
• Dependability and surety
(competence)
• Increase profits
• Public relations management
• Attract new participants (attendees)
• Acquisition and maintenance
(ongoing service) of industry
partners
• Solicit new members
Wissenschaftliches Programm • Samstag, 1. Dezember 2012 • Jahrestagung der DGA
0830–1000 Neues in der Andrologie – State of the Art 2012 – Teil 1
Raum Stanford
Vorsitz F. Tüttelmann (Münster/DE), M. Sohn (Frankfurt a. M. /DE)
0830
Kryptorchismus als andrologischer Faktor
S. Kliesch (Münster/DE)
0850
Varikozele – andrologische Relevanz in der Praxis
W. Weidner (Gießen/DE)
0910Fertilität und Sexualität bei systemischen Erkrankungen
M. Zitzmann (Münster/DE)
0930Alte Väter – genetische Risiken?
E. Nieschlag (Münster/DE)
0950
Diskussion
1000–1030
Pause
1030–1200
Neues in der Andrologie – State of the Art 2012 – Teil 2
Raum Stanford
Vorsitz
W. Krause (Marburg/DE), J. W. Jacobeit (Hamburg/DE)
1030
Medikamentöse Therapie der Erektilen Dysfunktion
U. Wetterauer (Freiburg i. Br./DE)
1050
ID 111
Ejakulationsstörungen
H. Porst (Hamburg/DE)
1110
Pelvic pain in der Andrologie
F. Wagenlehner (Gießen/DE)
1130
Wie viel Sexualmedizin benötigt die Andrologie?
F.-M. Köhn (München/DE)
1150
Diskussion
1200–1330 Pause
32
Wissenschaftliches Programm • Samstag, 1. Dezember 2012 • Jahrestagung der DGA
1215–1315 Vorsitz
Lunchsymposium Jenapharm GmbH & Co. KG
Hypogonadismus – aktuelle Aspekte aus Klinik und Forschung
W. Weidner (Gießen/DE), H. Sperling (Mönchengladbach/DE)
U. Wetterauer (Freiburg i. Br./DE)
1215
EAU Guidelines on male hypogonadism
G. Dohle (Rotterdam/NL)
1235
Hypogonadismus und Fettgewebe – Aspekte aus Grundlagenforschung und Klinik
H. M. Behre (Halle a. d. S./DE)
1255
Testosteronsubstitution in der Praxis – Tipps und Tricks
M. Zitzmann (Münster/DE)
1330–1430 Neues in der Andrologie – State of the Art 2012 – Teil 3
Raum Stanford
Raum Stanford
Vorsitz W.-B. Schill (Gießen/DE), G. Haidl (Bonn/DE)
1330Neue Vasektomie-Leitlinien
T. Diemer (Gießen/DE)
1350
Medikamente und Nahrungsergänzungsmittel bei idiopathischer Infertilität?
S. Grunewald (Leipzig/DE)
1410Fertilitätsprotektion und Kryokonservierung
M. Trottmann (München/DE)
1430 Verabschiedung
W. Weidner, A. Meinhardt (Gießen/DE)
33
Poster Sessions
1015–1215 Chair Poster Session 1 • Andrological Implications of Genital Tract Infections
J.-P. Allam (Bonn/DE)
P 1 Review of management of cases of acute epididymo- orchitis – how can we improve and
are our urological guidelines in need of updating?
*B. Hickerton, *D. Ellis, C. Mullooley, R. Gokhale, N. Parr (Merseyside/GB)
P 2 Leukocytes are associated with apoptosis in human spermatozoa
C. Mupfiga, D. Fisher, T. Kruger, *R. Henkel (Bellville/ZA)
P3
Testicular function in HIV-positive patients under stable antiretroviral therapy
*A. Pilatz, T. Discher, H.-C. Schuppe, F. Wagenlehner, W. Weidner, J. Lohmeyer
T. Diemer (Gießen/DE)
P4
Testicular atrophy after acute epididymitis/epididymo-orchitis – fact or fiction?
*A. Pilatz, F. Wagenlehner, H.-C. Schuppe, B. Altinkilic, W. Weidner (Gießen/DE)
P5
Correlation of seminal inflammatory and sperm quality parameters in patients with
CP/CPPS and infertility – is diagnostic value of seminal cytokine Interleukin-8 (sIL-8)
superior to elastase or peroxidase positive leukocytes?
*A. Rusz, A. Pilatz, R.-H. Bödeker, F. Wagenlehner, T. Diemer, H.-C. Schuppe, K. Steger
W. Weidner (Gießen/DE)
P6
Alpha-haemolysin differentially modulates innate immune responses in the
experimental murine epididymitis model
*T. Lang (Gießen/DE), C. Hudemann (Marburg/DE), S. Bhushan, S. Tchatalbachev
A. Meinhardt (Gießen/DE)
P7
Characteristics of staphylococcus aureus and E. coli, collected from infertile
men’s urethra
*A. Godovalov, T. Danielyan, L. Bykova, A. Dmitrishin (Perm/RU)
P8
Clinical and etiological features of nonspecific male urethritis
*A. Godovalov, T. Danielyan, L. Bykova, A. Dmitrishin (Perm/RU)
P9
Does HPV impact on male idiopathic infertility?
M. Kogan, K. Ibishev, *K. Shiranov (Rostov-on-Don/RU)
P 10 Uropathogenic E. coli inactivate host survival AKT signalling pathways in testicular cells
*Z. Zhang, S. Bhushan, S. Tchatalbachev, T. Chakraborty, A. Meinhardt (Gießen/DE)
34
Poster Sessions
P 12 Lipopolysaccharide inhibits mitochondrial membrane potential in human spermatozoa
through the activation of cannabinoid receptor-1 by sperm-generated anandamide
*A. Barbonetti, M. R. C. Vassallo, A. De Mutis, A. C. Giornetta, S. Francavilla
F. Francavilla (L‘Aquila/IT)
P 13 The effects of kerack used in Iran on sperm parameters and testis structure in adult mice
*M. Amini, M. Koruji (Tehran/IR)
P 14 Involvement of testosterone in the regulation of inflammatory responses in testicular
and immune cells
*M. Fijak, L.-J. Sauber, M. Walecki, E. Wahle, S. Bhushan, H. Hackstein, G. Schuler
A. Meinhardt (Gießen/DE)
P 15 Screening urinalyses for diagnosis of prostatitis and urogenital tuberculosis
E. Kulchavenya (Novosibirsk/RU)
P 16 Clinical features of male genital tuberculosis in Siberia
*E. Kulchavenya, D. Kholtobin (Novosibirsk/RU)
P 17 Efficiency of uro-vaxom in prophylaxis of relapse of chronic prostatitis
*E. Kulchavenya, E. Brizhatyuk (Novosibirsk/RU)
P 18 P 19 Male urethral condylomata – our experience
*A. Vives Sune, S. Camarena, O. Rajmil, G. Ortiz, E. Ruiz Castane (Barcelona/ES)
Testicular inflammation in infertile men
*T. Haggeney, A. Pilatz, T. Diemer, W. Weidner, H.-C. Schuppe, M. Bergmann (Gießen/DE)
P 167 Necrosis is the dominant cell dead pathway in UPEC induced epididymo-orchitis model
and is responsible for structural and functional damage of rat testis
*S. Bhushan, Y. Lu, S. Tchatalbachev (Gießen/DE), M. Marconi (Santiago/CL), M. Bergman
W. Weidner, T. Chakraborty, A. Meinhardt (Gießen/DE)
1015–1215 Poster Session 2 • Free Communications
Chair R. Middendorff (Gießen/DE)
P 20 Eurycoma longifolia (tongkat ali) as a potential herbal supplement for physically active
male and female seniors
*R. Henkel, R. Wang, S. Bassett, T. Chen, N. Liu, Y. Zhu, M. I. Tambi (Bellville/ZA)
P 21 Eurycoma longifolia extract at therapeutical concentrations does not negatively affect human sperm functions in vitro
N. Erasmus, M. Solomon, K. Fortuin, *R. Henkel (Bellville/ZA)
35
Poster Sessions
P 22 Algorithm for the surgical management of obstructive azoospermia
*K. Zaki Shaeer, O. Shaeer (Cairo/EG)
P 23 Common and hormone-specific inhibitory effects of sex steroids on testes development
in the rat
*R. Walczak-Jedrzejowska, J. Slowikowska-Hilczer, E. Oszukowska, K. Marchlewska
E. Filipiak, K. Kula (Lodz/PL)
P 24 FGFR3 as a potential marker for human spermatogonial stem cells
*K. von Kopylow, A.-N. Spiess, W. Schulze, H. Staege, H. Will, C. Kirchhoff (Hamburg/DE)
P 25 Effects of flutamide on the sperm membrane integrity, mitochondrial diaphorase
activity, and sperm morphology in adult boars – in vivo and in vitro approach
*M. Lydka (Krakow/PL), M. Piasecka, D. Gaczarzewicz (Szczecin/PL)
B. Bilinska (Krakow/PL)
P 26 Prenatal and neonatal exposure to flutamide alters androgen receptor expression in the
prostate of adult boars
*A. Hejmej, M. Kotula-Balak, K. Chojnacka, M. Łydka, B. Bilińska (Krakow/PL)
P 27 Effects of a murine germ cell-specific knockout of connexin 43 on connexin expression
in testis and fertility
*S. Günther, D. Fietz (Gießen/DE), K. Weider (Hanover/DE), M. Bergmann (Gießen/DE)
R. Brehm (Hanover/DE)
P 28 The effect of treatment with antioxidants/vitamins/aminoacids on semen quality in
idiopathic infertile males
M. Buividaite, *J. Erenpreiss (Riga/LV)
P 29 Androgen signaling disruption during prenatal and neonatal period affects Leydig cell
function in adult boar
*B. Bilińska, A. Hejmej, M. Kotula-Balak, M. Łydka (Krakow/PL)
P 30 Aromatase, androgen and estrogen receptors in bank vole spermatozoa
*M. Kotula-Balak, M. Łydka, A. Hejmej, B. Bilińska (Krakow/PL)
P 31 Aromatase and estrogen receptors expression at complete spermatogenesis and in
Sertoli cell only syndrome
*E. Oszukowska, M. Brys, E. Forma, K. Marchlewska, R. Walczak-Jedrzejowska
J. Slowikowska-Hilczer, K. Kula (Lodz/PL)
36
Poster Sessions
P 32 Transient pubertal administration of FSH together with triiodothyronine produces
quantitative reduction of spermatogenesis and endocrine function of the testes in
adulthood
*K. Marchlewska, K. Kula, R. Walczak-Jedrzejowska, E. Oszukowska, E. Filipiak
J. Slowikowska-Hilczer (Lodz/PL)
P 33 Three dimensional culture of rat testicular cells in collagen sponges
*K. Reuter, J. Wistuba, J. Ehmcke, S. Schlatt (Münster/DE)
P 34 Reduced numbers of Sertoli, germ, and spermatogonial stem cells in impaired
spermatogenesis
*L. Konrad, M. Borgers, M. Wolter, A. Hentrich, A. Stammler, M. Bergmann (Gießen/DE)
S. Kliesch (Münster/DE)
P 35 Sdf-1 mediated response of germ cell loss in male mouse testis after cytotoxic treatment
*B. Westernströer, N. Terwort, S. Schlatt, J. Ehmcke, J. Wistuba, N. Kossack (Münster/DE)
P 36 Human Sertoli cells produce high amounts of acetate that is under strict hormonal
control
*M. Alves, S. Socorro (Covilhã/PT), J. Silva, A. Barros, M. Sousa (Porto/PT), J. E. Cavaco
P. F. Oliveira (Covilhã/PT)
P 37 Visualization of sildenafil effects in testis
*C. Feuerstacke, S. Tasch, I. Schneider-Hüther, J. Volkmann, G. Eichner, D. Müller
R. Middendorff (Gießen/DE)
P 38 Visualisation of sildenafil effects in the epididymis
*A. Mietens, S. Tasch, I. Schneider-Hüther, G. Eichner, D. Müller, C. Feuerstacke
R. Middendorff (Gießen/DE)
P 39 Spermatogonial stem cells in marmoset monkeys – isolation and characterisation in vitro
*D. Langenstroth, N. Kossack, J. Gromoll, S. Schlatt (Münster/DE)
P 40 Morphological, immunohistochemical and histochemical study of rat prostate under
immunosuppression
M. Sokolowska, S. Sluczanowska-Glabowska, M. Piasecka, K. Kedzierska
K. Sporniak-Tutak, K. Ciechanowski, *M. Laszczynska (Szczecin/PL)
P 41 Hormonal regulation of Na+-H+ exchanger 3 (NHE-3) in Sertoli cells – a possible role for
estrogens in spermatogenesis
A. D. Martins, V. L. Simões, M. G. Alves, E. B. Cavaco, S. Socorro
*P. F. Oliveira (Covilhã/PT)
37
Poster Sessions
ID 5Results of a prospective analysis indicating an autoantibody prevalence
in patients with Peyronie´s disease
*A. Hauptmann, T. Diemer, W. Weidner, G. Bein, H. Hackstein (Gießen/DE)
P 11 From priapus to priapism
*A. Abdulhak, J. Witt, A. Labanaris, V. Zugor (Gronau/DE)
1015–1215 Poster Session 3 • Sperm Quality and Selection for ART
Chair B. Zorn (Ljubljana/SL)
P 42 Sperm DNA integrity defect of infertile male patients at IIUM fertility centre
*A. Y. Abdul Wahab, M. L. Md. Isa, A. M. Zainuddin, S. Abdul Rahman
N. Baharudin (Kuantan/MY)
P 43 Body Mass Index has no impact on sperm quality but on reproductive hormones
B. Mohamad Al-Ali, T. Gutschi , K. Pummer, R. Zigeuner (Graz/AT)
S. Brookman-May (Munich/DE), W. F. Wieland, *A. Aziz (Regensburg/DE)
P 44 Zech-selector – the common method for assisted reproduction technology?
*K. Dreier, S. Neururer, H. Ulmer, J. Zech (Innsbruck/AT)
P 45 Nemaspermic DNA fragmentation in non-leukocytospermic ejaculates is related with the
formation of 8-Hydroxy-2’-deoxyguanosine and it seems to be related to an endogenous
sperm defect
*A. Micillo, A. D‘Angeli, A. Pezzella, S. D‘Andrea, G. Cordeschi, E. Di Girolamo
F. Francavilla, S. Francavilla (L‘Aquila/IT)
P 46 Intra-acrosomal protein indicates disturbed acrosome activity and correlates with IgA
load on human spermatozoa
*K. Cox, I. Oltermann, M. Schlößer, V. Kistler, G. Haidl, J.-P. Allam (Bonn/DE)
P 47 Sperm vacuoles are not modified by freezing-thawing procedures
*N. Gatimel, R. D. Leandri, J. Parinaud (Toulouse/FR)
P 48 Epididymis response partly compensates for spermatozoa oxidative defects in snGPx4
and GPx5 double mutant mice
*A. Noblanc, M. Peltier, C. Damon-Soubeyrand, F. Saez, R. Cadet (Aubière/FR)
M. Conrad (Neuherberg/DE), J. Drevet, A. Kocer (Aubière/FR)
P 49 Seminal plasma microRNAs are differentially expressed in normozoospermia,
oligozoospermia and azoospermia
*T. Greither, N. Nalazek, M. Giebler, I. Hoffmann, H. M. Behre (Halle a. d. S./DE)
38
Poster Sessions
P 50 Piwi gene expression is associated with ejaculate parameters and male infertility
*M. Giebler, C. Mösinger, L. Müller, I. Hoffmann, T. Greither, H. M. Behre (Halle a. d. S./DE)
P 51 Lysophosphatidylcholine content in human spermatozoa depends on BMI?
*S. Pyttel, A. Nimptsch (Leipzig/DE), U. Jakop, K. Müller (Berlin/DE), U. Paasch
J. Schiller (Leipzig/DE)
P 52 A cross-platform cross-laboratory microarray study as a powerful tool to reveal gene
expression signatures of male infertility
*H. Cappallo-Obermann, W. Schulze, A.-N. Spiess (Hamburg/DE)
P 53 Sperm DNA fragmentation as assessed by tunel/mean values in fertile men and intra
individual variability
*M. Muratori, L. Tamburrino, M. Cambi, S. Marchiani, I. Natali, I. Noci, M. Maggi, G. Forti
E. Baldi (Florence/IT)
P 54 Characterisation of sumoylated proteins in human sperm
*S. Marchiani, L. Tamburrino, M. Muratori, D. Nosi, G. Forti, E. Baldi (Florence/IT)
P 55 Small human sperm vacuoles observed under high-magnification (x10000) – small
nuclear concavities linked to failure of chromatin condensation
*F. Boitrelle (Versailles/FR), F. Ferfouri, J.-M. Petit, M. Bergere (Poissy, Versailles/FR)
R. Wainer, M. Bailly (Versailles/FR), F. Vialard, M. Albert, J. Selva (Poissy, Versailles/FR)
P 56 Cryopreservation of human spermatozoa decreases the number of motile normal
spermatozoa, induces nuclear vacuolisation and chromatin decondensation – interests
of high-magnification for frozen/thawed sperm
*F. Boitrelle (Versailles/FR), M. Albert, C. Theillac, F. Ferfouri, M. Bergere
F. Vialaro (Poissy, Versailles/FR), R. Wainer, M. Bailly (Versailles/FR)
J. Selva (Poissy, Versailles/FR)
P 57 Cryptozoospermia negatively affects pre-implantation embryo development – results
from a study on 798 ICSI cycles with fresh ejaculated sperm
*F. M. Castiglioni, P. Sulpizio, G. Tesoriere, P. Testa, C. Lepadatu, S. Rofena
G. M. Colpi (Milan/IT)
P 58 Reliability of flow cytometry in quantifying antibody-molecules on sperm surface
F. Sciarretta, A. Sperandio, G. Cordeschi, *A. Barbonetti, M. R. C. Vassallo, A. De Mutis
S. Francavilla, F. Francavilla (L‘Aquila/IT)
39
Poster Sessions
P 59 MMP-12 expression is detectable in human seminal plasma and represents a predictor
for inflammatory processes in semen analysis
*A. Urbschat, P. Paulus, I. Wiegratz, H. Beschmann, F. Ochsendorf (Frankfurt a. M./DE)
P 60 Success predictors in homologous intrauterine insemination
H. Kostadinovic, M. Kolbezen, *B. Zorn (Ljubljana/SI)
P 61 Human sperm likes sugars – the role of the glycolytic pathway in male gamete
functionality
*C. Paiva (Coimbra/PT), A. Amaral (Coimbra/PT, Barcelona/ES)
J. Ramalho-Santos (Coimbra/PT)
ID 3
Asthenozoospermia in spinal cord-injured men – a model for shedding light upon the
contribution of glycolysis and mitochondrion in supporting sperm motility
*A. Barbonetti, M. R. C. Vassallo, Y. Leombruni, A. Di Rosa, S. Francavilla
F. Francavilla (L’Aquila/IT)
P 154 Pregnancy rate, semen analysis, varicocele profile in Surabaya 2007–2010
S. Alif, *F. Rizaldi (Surabaya/ID)
1015–1215 Chair Poster Session 4 • Determinants of Male Reproductive Health
R. Mitchell (Edinburgh/GB)
P 62 Morphometric and immunohistochemical evaluation of the testis of sexually mature
mice (Mus domesticus) intoxicated with Boron
J. E. Bustos-Obregon (Santiago/CL)
P 63 P 64 The impact of vitamin D on semen quality
*M. Gudipati, V. Hemingway, L. Nowak, S. Pearce, J. Stewart, K. McEleny (Newcastle/GB)
Increased urinary levels of endocrine disrupting chemicals in filaggrin gene null
mutation carriers – a cross-sectional population-based study
*U. Joensen, H. Frederiksen, N. Jørgensen, E. Rajpert-De Meyts, N. E. Skakkebæk
A.-M. Andersson, T. Menné, J. Thyssen (Copenhagen/DK)
P 65 Perfluorooctanesulfonate (PFOS) in serum negatively associated with testosterone
levels in healthy men
*U. Joensen (Copenhagen/DK), B. Veyrand, J.-P. Antignac (Nantes/FR), N. E. Skakkebæk
A.-M. Andersson (Copenhagen/DK), B. Le Bizec (Nantes/FR)
N. Jørgensen (Copenhagen/DK)
P 66 Psychological impact of fertility treatment among Malaysian men
*A. Y. Abdul Wahab, A. M. Zainuddin, R. Musa, A. F. Abdul Rahim, H. Mohd Yatim
S. K. Mohd Bustaman, N. Mohd Arifin (Kuantan/MY)
40
aktuell, seriös, praxisnah
Die Urologischen Nachrichten informieren Sie über
das Wichtigste aus Ihrem Fachgebiet.
G 134 57
06. 2012
Z e i t u n g f ü r D i e u r o lo g i e
www.biermann-medizin.de
Gießen/Marburg
Niere/Harnwege
Diagnose/Therapie
Im Zuge der Übernahmediskussion
werden Stimmen lauter, das Uniklinikum zum Land zurückzuholen. Der
Gießener Urologie-Chef Wolfgang
Weidner hält nichts davon. ( Seite 6
Von der Niere bis zur Urethra: Aktuelles zu Nierenzysten und Zystennieren,
Nierenschädigung, Harnwegsinfektionen, Interstitieller Zystitis, Harnröhren( Seite 9–17
chirurgie und mehr
Ein neuer Biomarker kann Blasenkrebs
früher anzeigen. Bei der Strahlentherapie fortgeschrittener Stadien erwies
sich die Kombination mit Chemothera( Seite 18
pie als erfolgreich.
Brauchen Urologen bald eine Hygienefachkraft?
Managementgesellschaft warnt vor zu strenger Auslegung des infektionsschutzgesetzes durch die landesregierungen
und neun Monate nach Inkrafttreten der Neufassung des Infektionsschutzgesetzes (IfSG) unterbreitete die Landesregierung NRW ihren
Entwurf zur Umsetzung des § 23 Abs. 5
und 8. Vor allem die Interpretation des
Absatzes 8 kann nach Ansicht der UroGmbH fatale Folgen für jede urologische Praxis haben. Geschäftsführer Dr.
Wolfgang Rulf fordert das Ministerium
zum Umdenken auf.
Eigentlich erwähnen die Absätze 5
und 8 des § 23 IfSG ausdrücklich Einrichtungen zum ambulanten Operieren. Doch die Uro-GmbH befürchtet,
dass durch „schwammige Formulie-
Streitpunkt
personelle ausstattung
Brisant ist nach Ansicht der Uro-GmbH
die Umsetzung des Absatzes 8, der die
Landesregierungen verpflichtet, durch
kenhaushygienikern und die
Bestellung von hygienebeauftragten Ärzten, einschließlich bis zum 31.
Dezember 2016, umzusetzen.“
Im Entwurf der Landesregierung wurde bei der
Interpretation der Regeln
eine Differenzierung zwischen Praxen und Krankenhäusern vorgenommen
– allerdings nicht bei der
Verpflichtung für Praxen
zu einer Hygienefachkraft.
„Es ist müßig darüber
nachzudenken, ob der
Landesregierung bei der
Formulierung ‚Hygienefachkraft‘ bewusst war,
dass es sich hier um eine
geschützte
Berufsbezeichnung
handelt“,
Händedesinfektion: notwendiges, aber nicht hinreichenmeint Rulf. „Hygienefachdes Kriterium für einen erfolgreichen Infektionsschutz.
kräfte müssen eine abgeRechtsverordnung Maßnahmen zur schlossene Berufsausbildung zur
Verhütung, Erkennung, Erfassung und Krankenschwester oder zum KrankenBekämpfung von nosokomialen Infek- pfleger, eine mehrjährige Berufstätigkeit und eine sich daran anschließentionen und Krankheitserregern mit
Resistenzen zu regeln. Acht Regeln sol- de zweijährige Zusatzweiterbildung
len dazu umgesetzt werden, eine heißt: haben. Selbst wenn, was selbstredend
nicht der Fall ist, die Praxen derartige
„die erforderliche personelle Ausstattung mit Hygienefachkräften und Kran- Fachkräfte finanzieren könnten,
Volker Witt - Fotolia.com
R
rungen“ im Gesetz auch
nicht operierende, aber
endoskopierende Praxen
und damit letztendlich alle
urologischen Praxen unter
die neuen gesetzlichen
Vorgaben fallen könnten.
Der
Hintergrund:
Absatz 5 fordert von den
Verantwortlichen innerbetriebliche Verfahrensweisen zur Infektionshygiene
in Hygieneplänen, um – in
Kombination mit § 23 Abs.
3 IfSG – die Weiterverbreitung von Krankheitserregern, insbesondere mit
Resistenzen, zu vermeiden. Dies sollte
jedoch mittlerweile in den urologischen Praxen problemloser Standard
sein. Gemäß § 23 Abs. 4 IfSG ist aber
darauf zu achten, dass das Auftreten
von Keimen mit Resistenzen und Multiresistenzen sowie deren Management organisiert und dokumentiert
wird. Verstöße gegen Absatz 4 können
mit 25.000 Euro sanktioniert werden.
Uro-GmbH
köln
[ms] Nach
Ansicht der Managementgesellschaft UroGmbH Nordrhein sollten
die Bestimmungen der
nordrhein-westfälischen
Landesregierung zum
neuen Infektionsschutzgesetz nicht Schule
machen. Den urologischen Praxen würden so
zusätzliche Personalkosten durch Hygienefachkräfte aufgebürdet
werden, fürchten die UroWolfgang Rulf
logen.
wären bei Weitem nicht ausreichend
Hygienefachkräfte auf dem Markt.“
KV nordrhein interveniert –
mit wenig erfolg
In der Folge hat die KV Nordrhein eine
Stellungnahme an die Landesregierung weitergeleitet. Die Einwände
seien im Ministerium aber nicht erhört
worden, berichtet die Uro-GmbH. Das
Ministerium habe nur auf die Forderung der festen Einstellung verzichtet.
Im Februar 2012 forderte die KV Nordrhein alle ambulant operativ tätigen
Vertragsärzte auf, die „Anforderungen
an die hygienische Aufbereitung von
Medizinprodukten“ umzusetzen. „Bei
genauer Durchsicht fällt auf, dass
diese sogar höhere Anforderungen an
die Aufbereitung stellen als die gesetzlich legitimierten Normen der Kommission am Robert Koch-Institut“,
verdeutlicht Rulf. „Zudem steht im
§ 23 Absatz 3 des IfSG, dass die Einhaltung des Standes der medizinischen Wissenschaft vermutet wird,
wenn die Empfehlungen des RKI eingehalten wurden. Weitgehende Anforderungen können nicht ernsthaft verlangt werden.“
W
( Quelle: Uro-GmbH Nordrhein
www.uro-gmbh.de
Trennung in Grund- und Spezialversorgung
D
ie KBV hatte am 24. April
dem Antrag „Begrenzte Leistung für begrenztes Geld –
Grundversorgung definieren“ des
Bayerischen
Facharztverbandes
(BFAV) und verschiedener KVen angenommen. Die Leistungen des EBM sollen „auf dem Boden valider Kriterien“
auf das im SGB V geforderte Maß
„wirtschaftlich, ausreichend, zweck-
✁
mäßig und notwendig“ (§ 12) angepasst werden.
„Ausdrücklich einbezogen und aufgefordert, daran mitzuwirken, sind
durch diesen Beschluss die Berufsverbände, denen ein großes Maß an Verantwortung für die Ausgestaltung dieser strategischen Vorgabe zukommt“,
betonte Dr. Wolfgang Bärtl, einer der
drei BFAV-Vorsitzenden, nach diesem
Erfolg.
sowohl auf Bundes- als auch auf Landesebene darin, die urologische Basisversorgung zu definieren“, so Dr.
Hartwig Kohl, Urologe und ebenfalls
Vorsitzender des BFAV, gegenüber den
Urologischen Nachrichten, „und zwar
so, dass diese Leistungen erstens an
das vom SGB geforderte Maß – wirtschaftlich, ausreichend, notwendig
und zweckmäßig – angepasst werden
und dass zweitens der deutsche Urologe von dieser Basisversorgung leben
kann“. Vordringliches Ziel sei es, alle
Mechanismen zu meiden, die zur
„Fortsetzung des Hamsterradeffektes“
führen können.
l
ausstieg
aus dem Hamsterrad
Nun sind also die Berufsverbände am
Zug, im Falle der Urologen der BDU.
„Die konkreten Aufgaben des BDU –
wie aller anderen Berufsverbände
auch – bestehen aus unserer Sicht
BFAV
berlin [ms] Nachdem sich die Kassenärztliche Bundesvereinigung (KBV)
auf ihrer Vertreterversammlung dafür
entschieden hat, bei der EBM-Reform in
Abstimmung mit den Berufsverbänden
eine medizinische Grundversorgung zu
definieren, liegt der Ball im Bereich Urologie jetzt beim BDU.
Hartwig
Kohl
eistungen von Ärzten
kann es nicht mehr geben,
wenn sie nicht bezahlt
werden.
regionale und
fachübergreifende abstimmung
Kohl betont, dass hierfür eine Abstimmung aller Berufsverbände erforderlich sei, um zu vermeiden, dass die
stringente
Leistungsrückführung
durch den einen Berufsverband zu
einer quasi „kompensatorischen“
Mehrleistung durch den anderen
Berufsverband führe. „Dies trifft ebenso auf die Bundesländer insgesamt zu:
Auch hier darf die Leistungsbegrenzung im einen Bundesland nicht zu
einem Honorarzuwachs in anderen
Bundesländern führen“, warnt Kohl.
Konkret soll laut Kohl die Basisversorgung von einer weiterführenden
Fortsetzung s. Seite 3 (
Biermann Verlag GmbH, Otto-Hahn-Str. 7, 50997 Köln, G 420 41 PVST, DP AG, Entgelt bezahlt
ebm-reform: länder-Antrag angenommen – Berufsverbände nach KbV-beschluss am Zug
Einfach abonnieren, am schnellsten per Fax: 0201-747281-10
Gewünschte Zahlungsweise
Ja, ich möchte die Urologischen Nachrichten abonnieren!
❏ gegen Rechnung
❏ bequem und bargeldlos per Lastschrift
Schicken Sie mir bitte die Urologischen Nachrichten für ein Jahr (12
Hefte) zum Preis von jährlich 98 Euro inkl. MwSt. und Versandkosten
(Inland). Das Abonnement verlängert sich automatisch um ein weiteres
Jahr, wenn es nicht zwölf Wochen vor Ablauf des Bezugsjahres gekündigt wird.
Der Einzugsauftrag gilt bis auf Widerruf
und endet automatisch bei Beendigung
des Abonnements.
Name, Vorname
Kontoinhaber
Kontonummer
BLZ
Straße, Nr.
Institut (Ort)
PLZ, Ort
Datum, Unterschrift
Datum, Unterschrift
Diese Bestellung kann innerhalb von
10 Tagen (Datum des Postvermerks)
widerrufen werden bei Publikom Z
Leserservice
Heinrichstraße 73, 40239 Düsseldorf
Tel.: 0561-60280-461
Fax: 0561-60280-469
E-Mail: [email protected]
Datum, Unterschrift
Biermann Verlag GmbH Otto-Hahn-Str. 7 50997 Köln Tel.: 02236-376-0 E-Mail: [email protected]
Poster Sessions
P 67 Clinical evaluation of the male partners of infertile couples – a waste of time?
*M. Walschaerts, R. Mieusset, F. Isus, G. Massat, E. Huyghe, P. Plante
L. Bujan (Toulouse/FR), P. Thonneau (Tunis/TN)
P 68 Development of semen quality during young adulthood – longitudinal follow-up of two
Finnish cohorts
A. Perheentupa, *S. Sadov, R. Rönkä, H. E. Virtanen, M. Vierula, J. Matomäki (Turku/FI)
N. Jørgensen, N. E. Skakkebæk (Copenhagen/DK), J. Toppari (Turku/FI)
P 69 Testis and epididymis morphology in rats treated with soya isoflavones from prenatal
life until sexual maturity
*M. Marchlewicz, I. Baranowska-Bosiacka, A. Grzegrzółka, D. Szypulska, A. Kolasa
A. Kondarewicz, E. Duchnik, B. Wiszniewska (Szczecin/PL)
P 70 Perinatal origins of adult Leydig cells and function – role of developmental androgens
*K. Kilcoyne (Edinburgh/GB), K. De Gendt (Belgium/BE), N. Atanassova (Sofia/BG)
S. Macpherson, A. Dean, S. van den Driesche, L. Smith, R. M. Sharpe (Edinburgh/GB)
P 71 Effects of Quercetin on mRNA expression of steroidogenesis genes in primary cultures
of Leydig cells treated with Atrazine
*S. Abarikwu (Redemption City/NG), A. Pant (Lucknow/IO), E. Farombi (Ibadan/NG)
P 72 The identification of pre-diabetes condition with ARIC algorithm, predicts long-term CV
events in patients with erectile dysfunction
*G. Corona, G. Rastrelli, A. Silveri, M. Monami (Florence/IT), A. Sforza (Bologna/IT)
G. Forti, E. Mannucci, M. Maggi (Florence/IT)
P 73 Semen parameters in Estonian fertile men
*K. Pomm, K. Ehala-Aleksejev, M. Punab (Tartu/EE)
P 74 The expression of metalloproteinases 9 and 2, and their tissue inhibitors 1 and 2 as
potential markers of asthenozoospermia
*E. M. Kratz, A. Kałuża, B. Kowalska-Olejnik, M. Zimmer, R. Fiutek
M. Ferens-Sieczkowska (Wrocław/PL)
P 75 The impact of paternal and maternal smoking on reproductive parameters of
adolescent men
*J. Axelsson (Malmö/SE), L. Rylander, A. Rignell-Hydbom (Lund/SE), K. Ågren Silfver
A. Stenqvist, A. Giwercman (Malmö/SE)
P 76 Spermatogonial expansion in marmoset testes
*T. T. K. Tran, N. M. Kossack, J. Ehmcke, S. Schlatt (Münster/DE)
42
Poster Sessions
P 77 Oxidative protein damage and oxidative stress markers in the seminal plasma of
subfertile men
*E. M. Kratz, M. Ferens-Sieczkowska, M. Zimmer, A. Piwowar (Wrocław/PL)
P 78 Mixed testicular atrophy related to atherosclerosis – further lessons from the
ApoE(-/-)/LDL receptor(-/-) double knockout mouse model
*K. Steinfeld, R. Middendorff, M. Kampschulte (Gießen/DE)
A. Langheinrich (Frankfurt a. M./DE), G. Krombach, T. Linn (Gießen/DE)
C. Mühlfeld (Hanover/DE), A. Pilatz, A. Paradowska-Dogan, B. Altinkilic, M. Bergmann
W. Weidner (Gießen/DE)
P 79 Effects of in-utero exposure to environmental agents on human fetal testis development
and function using a xenograft approach
*R. Mitchell, A. Calarrao, S. van den Driesche, C. McKinnell, S. MacPherson, R. Anderson
H. Wallace, C. Kelnar, P. Saunders, R. M. Sharpe (Edinburgh/GB)
P 80 Non-linear association between androgen receptor CAG repeat length and reproductive
parameters in fertile European and Inuit men
*L. J. Brokken (Malmö/SE), L. Rylander, B. A. Jönsson (Lund/SE), M. Spano (Rome/IT)
H. S. Pedersen (Nuuk/GL), J. K. Ludwicki (Warsaw/PL), V. Zviezdai (Kharkiv/UA)
D. Bizzaro (Ancona/IT), G.-C. Manicardi (Reggio Emilia/IT), G. Toft (Aarhus/DK)
J. P. Bonde (Copenhagen/DK), A. Giwercman, Y. Lundberg Giwercman (Malmö/SE)
P 81 Differentiation of seminal leukocyte subpopulations by flow cytometry
*S. Stötzel, A. Pilatz, M. Lohmeyer, T. Diemer, F. Wagenlehner, J. Lohmeyer
H.-C. Schuppe, W. Weidner, T. Linn (Gießen/DE)
P 82 Comparative analysis of morphological changes in mice testes following nano- and
micro-dispersed manganese oxide (III, IV) effect
*O. V. Lebedinskaya, N. V. Zaitseva, M. A. Zemluanova, V. N. Zvezdin, S. V. Melekhin
E. V. Saenko, A. V. Tarantin, R. R. Makhmudov, T. I. Akaf’eva (Perm/RU)
1015–1215 Chair Poster Session 5 • Genetics and Epigenetics
C. Krausz (Florence/IT)
P 83 Mutation studies in the CFTR gene in Asian-Indian subjects with congenital bilateral
absence of vas deferens – report of two novel mutations and four novel variants
K. Sachdeva (Jalandhar/IO)
P 84 Molecular analysis of sex chromosomes in 47,XYY men and patients with Klinefelter´s
syndrome and/or sex chromosome polysomy
*V. Chernykh, L. Kurilo, O. Ryzhkova, E. Bliznetz, A. Chukhrova, A. Polyakov (Moscow/RU)
43
Poster Sessions
P 85 Human catalase c-262t polymorphism and male infertility
*S. Saboohi, Z. Salehi, M. H. Bahadori (Guilan/IR)
P 86 Molecular markers of male infertility – single nucleotide polymorphism of protamine-1
and -2 genes and human sperm protamine deficiency
A. Kazienko, A. Rymaszewska, K. Gill, D. Gaczarzewicz, R. Kurzawa
M. Laszczyska (Szczecin/PL), M. Fraczek, M. Kurpisz (Poznan/PL)
*M. Piasecka (Szczecin/PL)
P 87 From sperm to early embryo stages: potential functions of acetylated-histone-bound
genes for idiopathic male infertility (a bovine model)
*Y. Yang, G. Sarode, B. Samans (Gießen/DE), S. Krebs, H. Blum, E. Wolf (Munich/DE)
A. Wehrend, W. Weidner, K. Steger, U. Schagdarsurengin (Gießen/DE)
P 88 Mutations in the NR5A1 gene encoding steroidogenic factor 1 cause spermatogenic
failure
*F. Tüttelmann, A.-C. Tewes, A.-L. Bröcher, S. Kliesch, P. Wieacker, A. Röpke (Münster/DE)
P 89 Y-chromosome-linked CNVs in the Spanish population
*D. G. Lo Giacco, E. Ars, P. Ruiz, L. Bassas, S. Joaquim, O. Rajmil
E. Ruiz Castañé (Barcelona/ES), C. Krausz (Florence/IT)
P 90 The PARP2 gene is associated with male subfertility and prostate cancer protection
*M. Bentmar Holgersson, Y. Ruhayel, A. Giwercman
Y. Lundberg Giwercman (Malmö/SE)
P 91 Polymorphisms in the follicle-stimulating hormone receptor affect receptor activity in
vitro
*I. Lindgren, A. Giwercman, Y. Lundberg Giwercman (Malmö/SE)
P 92 Sperm Y.X-chromosome ratio and exposure to persistent organic pollutants in young
men from the Faroe Islands
*L. Kvist, Y. Lundberg Giwercman (Malmö/SE), P. Weihe (Torshavn/FO)
T. Kold Jensen (Odense, Copenhagen/DK), P. Grandjean (Odense/DK, Harvard/GB)
A. Giwercman (Malmö/SE)
P 93 Decreased transactivating capability due to a deletion in the transactivating domain of
the androgen receptor gene is associated with testicular cancer and male infertility
*H. Rastkhani, A. Giwercman (Malmö/SE), E. Rajpert-De Meyts (Copenhagen/DK)
N. JØrgensen (Copenhagen/DK), Y. Lundberg Giwercman (Malmö/SE)
44
Poster Sessions
P 94 Array-CGH studies in male infertility – deletion burden on the X-chromosome and sex
chromosomes-linked CNVs
*C. Chianese (Florence/IT), D. G. Lo Giacco, (Barcelona/ES), C. Giachini
F. Daguin (Florence/IT), E. Rossi (Pavia/IT), E. Ars, E. Ruiz-Castanè (Barcelona/ES)
G. Forti, C. Krausz (Florence/IT)
P 95 Is abnormal karyotype the essential reason to cancel azoospermic men from
testicular biopsy?
*J. K. Wolski, J. Brycz-Witkowska, H. Stanczak, E. Budna, B. Biarda, P. Kluge, K. Koziol
P. Lewandowski (Warsaw/PL)
P 96 Lack of evidence for a direct association of Y-chromosome microdeletions in children
with testicular maldescent
C. Mamoulakis (Heraklion/GR), *F. Dimitriadis (Thessaloniki/GR), A. Chatzikyriakidou
E. Vlachopoulou (Ioannina/GR), F. Sofras, (Heraklion/GR), I. Georgiou
N. Sofikitis (Ioannina/GR)
P 97 Influence of androgens on the differentiation of human regulatory T cells
*M. Walecki, N. Baal, A. Pilatz, A. Meinhardt, M. Fijak (Gießen/DE)
P 98 Recurrent X-chromosome-linked deletions – discovery of new genetic factors in male
infertility
*D. G. Lo Giacco (Barcelona/ES), C. Chianese (Florence/IT), E. Ars
E. Ruiz Castañé (Barcelona/ES), G. Forti, C. Krausz (Florence/IT)
P 99 The molecular role of Tcd1b in transmission ratio distortion
*Y. Charron, H. Bauer, B. G. Herrmann (Berlin/DE)
P 100 Treatment of patients with a late diagnosis of Klinefelter´s syndrome with testosterone
undecanoate for a duration of up to 5 years
*A. Haider (Bremerhaven/DE), F. Saad (Berlin/DE, Ajman/UA)
P 101 The Münster EXAKT project – cardiovascular risk factors in Klinefelter´s patients and
healthy controls
*M. Zitzmann, S. Werler, R. Bongers, S. Kliesch, J. Gromoll, F. Tüttelmann (Münster/DE)
P 102 Münster-EXAKT – X-chromosome inactivation in two Klinefelter´s-twin pairs
*R. Bongers, S. Werler, J. Gromoll, S. Kliesch, F. Tüttelmann, M. Zitzmann (Münster/DE)
P 103 The Münster EXAKT study – microarray gene expression analysis in blood samples of
Klinefelter´s patients
*S. Werler, R. Bongers (Münster/DE), P. Hüppe (Münster, Essen/DE), J. Seggewiss
J. Wistuba, F. Tüttelmann, M. Zitzmann, J. Gromoll (Münster/DE)
45
Poster Sessions
1015–1215 Poster Session 6 • New Horizons in Andrology & Testicular Cancer
Chair E. Baldi (Florence/IT)
P 104 Fibronectin on the surface of human spermatozoa – a new marker of sperm quality
*F. Torabi, H. Heidari-Vala, M. M. Akhondi, N. Lakpour, A. H. Zarnani, J. Mahmoudian
A. R. Mahmoudi, M. R. Sadeghi (Tehran/IR)
P 105 NAMPT is expressed and released by human spermatozoa depending on maturation
stage
*S. Thomas, A. Garten, M. Schaab, S. Grunewald, W. Kiess, J. Kratzsch
U. Paasch (Leipzig/DE)
P 106 Testicular peritubular cells influence spermatogonial stem cells via the extracellular
matrix proteoglycan decorin and may contribute to the spermatogonial stem cell niche
in man
*S. Windschüttl, F. Flenkenthaler, T. Fröhlich (Munich/DE), S. Schlatt (Münster/DE)
H. Schorle (Bonn/DE), U. Welsch, G. J. Arnold, A. Mayerhofer (Munich/DE)
P 107 Assessment of sperm concentration and viability by automated image cytometry
*D. L. Egeberg (Copenhagen/DK), S. Kjærulff (Allerød/DK), C. Hansen
J. H. Petersen (Copenhagen/DK), M. Glensbjerg (Allerød/DK), N. E. Skakkebæk
N. Jørgensen, K. Almstrup (Copenhagen/DK)
P 108 Seminal, ultrasound and psychobiological correlates of metabolic syndrome in male
subjects of infertile couples
*M. Maggi, F. Lotti, G. Corona, S. Degli Innocenti, E. Filimberti, V. Scognamiglio
L. Vignozzi, G. Forti (Florence/IT)
P 109 Seminal apoptotic M540 bodies originate from the testis: a study in a cohort of infertile
subjects
*M. Maggi, F. Lotti, L. Tamburrino, S. Marchiani, M. Muratori, G. Corona, M. G. Fino
G. Forti, E. Baldi (Florence/IT)
P 110 Sperm oxidative DNA damage increases with age even in highly selected Nellore bulls
*J. Torres Carreira (São José do Rio Preto/BR), J. Teramachi Trevisan (Araçatuba/BR)
L. H. Rodrigues (Jaboticabal/BR), S. H. Venturoli Perri (Araçatuba/BR)
C. Silva (Sertãozinho/BR), I. Resende de Carvalho, P. Barbosa da Costa Gomes
B. Kipper, M. Burkhardt de Koivisto (Araçatuba/BR)
P 111 Feasibility of the testosterone-inducible CMG2 protein as biomarker for prostate
carcinoma
*S. Pelka, M. Marcou, T. Greither, P. Fornara, H. M. Behre (Halle a. d. S./DE)
46
Poster Sessions
P 112 Molecular influence of androgens on adipogenic differentiation of human SGBS
preadipocytes
*M. Kraus, T. Greither (Halle a. d. S./DE), M. Wabitsch (Ulm/DE)
H. M. Behre (Halle a. d. S./DE)
P 113 Androgen receptor expression in stromal and epithelial prostate cancer tissue
Specimens
*L. Tamburrino, F. Salvianti, S. Marchiani, G. Nesi, M. Lanciotti, M. Carini, G. Forti
P. Pinzani, E. Baldi (Florence/IT)
P 114 Reproductive function in middle-aged males – healthy men versus male partners of
infertile couples
*K. Ausmees, R. Mändar, P. Korrovits, G. Timberg, M. Punab (Tartu/EE)
P 115 Impact of childhood maltreatment on psychological state and sexual performance of
men facing timed intercourse (TI)
*C. Bak, J. S. Byun, J. H. Gwak, H. H. Seok, S. W. Lyu, T. K. Yoon (Seoul/KR)
P 116 Metachronous bilateral testis tumors with different histology – a case report
*J. P. Peralta, C. Rabaça, A. Sismeiro, R. Godinho, P. Conceição (Coimbra/PT)
P 117 Pituitary transforming gene 1 (PTTG1) expression in seminoma
F. Pierconti, M. Martini, G. Grande, T. Cenci, G. Gulino, G. Schinzari, L. M. Larocca
A. Pontecorvi, L. De Marinis, *D. Milardi (Rome/IT)
P 118 Early detection of carcinoma in situ of the testis with a new non-invasive method
*J. E. Elzinga-Tinke, G. Dohle, L. Looijenga (Rotterdam/NL)
P 119 Testicular cancer – awareness and testicular self examination in a Portuguese university
setting
*I. Braga (Braga/PT), N. Louro, J. LaFuente de Carvalho, A. Fraga (Porto/PT)
P 120 Delayed orchidectomy after primary chemotherapy for metastatic testicular cancer
*R. Donat, S. Ramsey, G. Kerr, G. Howard (Edinburgh/GB)
P 121 Biological hypogonadism and abnormal sperm in males affected by testicular cancer
*B. Zorn, Š. Breda, P. Marija, O. Jožko, K. Andreja (Ljubljana/SI)
P 122 Prevalence of intratubular germ cell neoplasia in testicular biopsies of infertile Iranian
men
*H. Soltanghoraee, F. Pourkeramati, M. M. Akhondi, N. Amirjanati (Tehran/IR)
47
Poster Sessions
P 123 Variations in testosterone pathway genes and susceptibility to testicular cancer in
Norwegian men
W. Kristiansen, *E. Aschim, J. Andersen, O. Witczak, S. Fosså, T. B. Haugen (Oslo/NO)
P 124 Genetic variations in signal transduction pathways and risk of testicular germ cell
tumour in a large Swedish-Norwegian case-parent, case-control study
R. Karlsson (Stockholm/SE), *W. Kristiansen, K. E. Andreassen, E. L. Aschim (Oslo/NO)
R. M. Bremnes (Tromsø/NO), O. Dahl (Bergen/NO), S. D. Fosså (Oslo/NO)
O. Klepp (Ålesund/NO), C. W. Langberg (Oslo/NO), A. Solberg (Trondheim/NO)
S. Tretli (Oslo/NO), P. K. Magnusson, H.-O. Adami (Stockholm/SE), T. B. Haugen
T. Grotmol (Oslo/NO), F. Wiklund (Stockholm/SE)
1015–1215 Poster Session 7 • Andrology along the Lifeline & Metabolic Syndrome and Reproductive Function & Hypogonadism
Chair N. JØrgensen (Copenhagen/DK)
P 125 Evaluation of oxidative stress in diabetic patients with erectile dysfunction
*F. A. Escórcio de Almeida, M. Almeida, N. Louro, J. LaFuente Carvalho, S. Ribeiro
A. Fraga (Porto/PT)
P 126 Effect of the metabolic syndrome on male hormonal status and sperm function – a case
controlled pilot study
*K. Leisegang, R. Henkel (Bellville/ZA), P. Bouic (Tygerberg/ZA)
A. Udodong (Bellville/ZA)
P 127 Restoring testosterone to normal levels in elderly men is efficacious in weight reduction
a follow-up study over 5 years
*A. Haider (Bremerhaven/DE), F. Saad (Berlin/DE, Ajman/UA)
P 128 Side effect profile of long-term treatment of elderly hypogonadal men with testosterone
undecanoate
*A. Haider (Bremerhaven/DE), F. Saad (Berlin/DE, Ajman/UA)
P 129 “Late onset hypogonadism” is not an isolated condition – comorbidities in elderly
hypogonadal men presenting or referred to urological institutions in Germany
*A. Haider (Bremerhaven/DE), A. Yassin (Ajman/UA, Dresden, Norderstedt/DE)
F. Saad (Berlin/DE, Ajman/UA)
P 130 The pharmacodynamics of enclomiphene citrate (Androxal®) in men with secondary
hypogonadism indicates that it acts as a restorative therapy rather than as a
replacement therapy
*R. Wiehle, G. Fontenot, M. Rosner, J. Podolski (The Woodlands, TX/US)
48
Poster Sessions
P 131 Testosterone and cardiovascular risk in patients with erectile dysfunction
*G. Rastrelli, G. Corona (Florence/IT), G. Balercia (Ancona/IT)
A. Sforza (Bologna/IT), G. Forti, M. Maggi (Florence/IT)
P 132 Investigation on psychological symptoms improves ANDROTEST accuracy in predicting
hypogonadism in subjects with sexual dysfunction
*G. Rastrelli, G. Corona, E. Bandini, C. Strada, E. Maseroli, V. Ricca, C. Faravelli
E. Mannucci, M. Maggi (Florence/IT)
P 133 Testosterone supplementation improves adipose tissue function in animal model of
metabolic syndrome
*E. Maneschi, A. Morelli, L. Vignozzi, S. Filippi, I. Cellai, P. Comeglio, T. Mello
B. Mazzanti (Florence/IT), A. Calcagno (Padua/IT), G. B. Vannelli (Florence/IT)
R. Vettor (Padua/IT), M. Maggi (Florence/IT)
P 134 Is psychological stress associated with reduced semen quality? A cross-sectional study
among 949 healthy young Danish men
*L. Nordkap, N. JØrgensen, T. Kold Jensen (Copenhagen/DK)
P 135 Comparative efficacy of the anastrasol for the treatment of idiopathic infertility in men
with normal BMI and obesity
*O. Tazhetdinov, S. Gamidov, R. Ovchinnikov, A. Popova (Moscow/RU)
P 136 Anti-inflammatory effect of androgen receptor activation in human BPH cells
*L. Vignozzi, I. Cellai, A. Morelli, L. Lombardelli, R. Santi, P. Comeglio, S. Filippi, G. Nesi
M. Gacci (Florence/IT), L. Adorini (New York City, NY/US), M.-P. Piccinni
M. Maggi (Florence/IT)
P 137 Is metabolic syndrome a useless category in subjects with high cardiovascular
risk? – results from a cohort study in men with erectile dysfunction
*G. Corona, M. Monami, G. Rastrelli (Florence/IT), A. Sforza (Bologna/IT), G. Forti
E. Mannucci, M. Maggi (Florence/IT)
P 138 Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate
inflammation
*L. Vignozzi, M. Gacci, I. Cellai, R. Santi (Florence/IT), G. Corona (Bologna/IT)
A. Morelli, G. Rastrelli, P. Comeglio, G. Nesi (Florence/IT), C. de Nunzio
A. Tubaro (Rome/IT), M. Maggi (Florence/IT)
P 139 Waist circumference and metabolic syndrome in relation to semen quality and serum
reproductive hormone levels among Estonian fertile men
*K. Ehala-Aleksejev, K. Pomm, M. Punab (Tallinn/EE)
49
Poster Sessions
P 140 Mechanism of action of phosphodiesterase type 5 inhibition in metabolic-syndromeassociated prostate alterations – an experimental study
*L. Vignozzi, A. Morelli, P. Comeglio, S. Filippi, E. Sarchielli, E. Maneschi, I. Cellai
M. Gacci, G. B. Vannelli (Florence/IT), A. Lenzi (Rome/IT), M. Maggi (Florence/IT)
P 141 Sperm characteristics in an animal model of metabolic syndrome
*S. Marchiani, A. La Barbera, S. Filippi, L. Vignozzi, G. Forti, M. Maggi
E. Baldi (Florence/IT)
P 142 Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced
testicular dysfunction in the rat
*F. Dimitriadis (Thessaloniki/GR), P. Tsounapi, M. Saito (Yonago/JP)
S. Koukos (Ioannina/GR), S. Shimizu, K. Satoh, A. Takenaka (Yonago/JP)
N. Sofikitis (Ioannina/GR)
P 143 Has metabolic syndrome any effect on reproductive characteristics in overweight
males?
*J. M. Andersen, O. Witczak, E. L. Aschim, H. Herning (Oslo/NO)
R. Sandbu (Tønsberg/NO), T. Mala (Oslo/NO), J. Hjelmesæth (Tønsberg/NO)
T. B. Haugen (Oslo/NO)
ID 19Association between UGT2B17genotype and testosterone substitution dosages?
*A. K. Bang, N. Jørgensen, A. Juul (Copenhagen/DK)
1015–1215 Chair Poster Session 8 • Sexual Medicine & Non-Obstructive Azoospermia
M. Maggi (Florence/IT)
P 147 Perceived reduced sleep-related erections in subjects with erectile dysfunction:
psychobiological correlates
*G. Rastrelli (Florence/IT), G. Corona (Florence, Bologna/IT), G. Balercia (Ancona/IT)
A. Sforza (Bologna/IT), G. Forti, E. Mannucci, M. Maggi (Florence/IT)
P 161
Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction
and higher risk of major adverse cardiovascular events
*G. Rastrelli, G. Corona, M. Monami, C. Melani, D. Balzi (Florence/IT)
A. Sforza (Bologna/IT), G. Forti, E. Mannucci, M. Maggi (Florence/IT)
50
Poster Sessions
P 162 Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual
dysfunction
*G. Rastrelli, G. Corona, E. Maseroli (Florence/IT), G. Balercia (Ancona/IT)
A. Sforza (Bologna/IT), G. Forti, E. Mannucci, M. Maggi (Florence/IT)
P 163 Two unconventional risk factors in estimating risk of major adverse cardiovascular
events in subjects with erectile dysfunction – low education and reported partner’s
hypoactive sexual desire in comparison with conventional risk factors
*G. Rastrelli, G. Corona, A. D. Fisher, A. Silverii, E. Mannucci, M. Maggi (Florence/IT)
P 164 Testosterone/estradiol ratio regulates NO-induced bladder relaxation an
responsiveness to PDE5 inhibitors
*L. Vignozzi, S. Filippi, A. Morelli, P. Comeglio, I. Cellai, E. Sarchielli, E. Maneschi
R. Mancina, G. B. Vannelli, M. Gacci, M. Maggi (Florence/IT)
P 165
“It takes two to tango” – the relational domain in a cohort of subjects with erectile
dysfunction (ED)
*V. Boddi, G. Corona, M. Maggi (Florence/IT)
P 144 Use of ethnicity-specific sequence tag site markers for Y-chromosome microdeletion
studies in non obstructive azoopsermic males
K. Sachdeva (Jalandhar/IO)
P 145 Expression of testosterone in Leydig cells of infertile patients with non-obstructive
azoospermia (NOA)
N. Kneževi, V. Kozina, A. Vukasovi, *D. Jezek (Zagreb/HR)
P 148 Our experience of microTESE in men with non-obstructive azoospermia
*O. Tazhetdinov, S. Gamidov, A. Popova, R. Ovchinnikov, N. Kamaletdinov
A. Schegolev (Moscow/RU)
P 150 Proteomic analysis of seminal plasma from normozoospermic and non-obstructive
azoospermic (NOA) men to discover new markers
*A. Meyfour, N. Lakpour, M. M. Akhondi, M. R. Sadeghi (Tehran/IR)
P 152 Gorlin-Goltz syndrome – a rare cause of male infertility
*K.-G. Ballauf, C. Protzel, C. Kakies, H. Müller, O. W. Hakenberg (Rostock/DE)
51
Poster Sessions
P 153 Ultrastructure of cultured spermatogenic cells in testicular materials of non-obstructive
azoospermic patients
*E. Yaprak, O. Arda, T. Irez (Istanbul/TR)
P 146 Circumcision and male sexual health – a predictive analysis
*J. Dias, R. Amorim (Vila Nova de Gaia/PT), R. Freitas (Porto/PT), P. Espiridião
L. Xambre, L. Ferraz (Vila Nova de Gaia/PT)
P 155 Multifactorial etiology of erectile dysfunction in patients with prostate carcinoma
treated by radiotherapy
*A. Mancini, L. Tagliaferri, S. Raimondo (Rome/IT), R. Festa (Ancona/IT), G. Mantini
G. C. Mattiucci, S. Luzi, A. Pontecorvi, V. Valentini, N. Cellini (Rome/IT)
P 156 Inhibition of circulating angiogenic cells from healthy men is associated with a TNF
dependent activation of caspase cascade and to mitochondrial depolarization
*S. Francavilla, A. D’Angeli, A. Barbonetti, S. D’Andrea, M. Di Padova, S. Filipponi
E. Alesse, F. Francavilla (L’Aquila/IT)
P 149 SIEDY Scale 3, a new instrument to detect sychological component in subjects with
erectile dysfunction
*G. Corona, V. Ricca, E. Bandini, G. Rastrelli, H. Casale (Florence/IT)
E. A. Jannini (L’Aquila/IT), A. Sforza (Bologna/IT), G. Forti, E. Mannucci
M. Maggi (Florence/IT)
P 151 Thyroid hormones and male sexual function
*G. Corona (Florence/IT), F. Wu (Manchester/GB), G. Forti (Florence/IT)
D. Lee (Manchester/GB), D. O’Connor (Leeds/GB), T. O’Neill (Manchester/GB)
N. Pendleton (Salford/GB), G. Bartfay (Szeged/HU), S. Boonen (Leuven/BE)
F. Casanueva (Santiago de Compostela /ES), J. Finn (Manchester/GB)
A. Giwercman (Malmo/SE), T. Han (Hampstead/GB), I. Huhtaniemi (London/GB)
K. Kula (Lodz/PL), M. Lean (Glasgow/GB), M. Punab (Tartu/EE)
D. Vanderschueren (Leuven/BE), E. A. Jannini (L’Aquila/IT)
E. Mannucci (L’Aquila, Florence/IT), M. Maggi (Florence/IT)
P 157 52
Ejaculatory disorders as a result of antituberculous therapy
*E. Kulchavenya, D. Kholtobin (Novosibirsk/RU)
Poster Sessions
P 158 Sexual health of Siberians
*E. Kulchavenya, E. Brizhatyuk, D. Kholtobin (Novosibirsk/RU)
P 159 P 160 Women as a cause of male sexual dysfunction
*E. Kulchavenya, E. Brizhatyuk, D. Kholtobin, A. Osadchiy (Novosibirsk/RU)
Ejaculatory disorders in Southerners and Siberians
*E. Kulchavenya, E. Brizhatyuk (Novosibirsk/RU)
Order online today and save up to 20% off the regular
price on individual print subscriptions for 2013.
Free onlin
e
access w
ith your
individu
al print
subscrip
tion!
Increased Impact Factor 3.796
Seminars in Reproductive Medicine
International Subscription Rates
Editor-in-Chief: B.R. Carr
Europe, Africa, Asia, Australia
[email protected]
Individuals: €322 €259
Institutional: €890
Please add handling charges: €54
2013 Volume 31 / 6 issues p.a. / ISSN 1526-8004
Seminars in Reproductive Medicine is a
topic-specific, indexed review journal that
provides in-depth coverage of important
advances in the understanding of normal
and disordered human reproductive
function, as well as new diagnostic and
interventional techniques
www.thieme.com
USA and Canada
[email protected]
Individuals: $299 $239
Institutional: $859
Mexico, Central and South America
Contact [email protected]
Individuals: $326 $261
Institutional: $886
Customers in Bangladesh, Bhutan,
India, Nepal, Pakistan, Sri Lanka:
Contact [email protected]
for subscription rates in INR.
Special introductory rates are only valid for new subscribers and are limited to the first year of subscription. Only qualified professionals and students
are eligible for individual subscriptions. Orders from individuals must include the recipient’s name and private address, and be paid by private funds.
2012 ECA Thieme SRM Ad.indd 1
13.07.2012 16:53:07
Meeting Calendar
Tuesday, 27 November 2012
1630–1830
EAA “Clinical Andrologist” written examination
Room Berlin
Wednesday, 28 November 2012
0900–1200
EAA “Clinical Andrologist” oral examination
Room Berlin
2000–2300
EAA Executive Council Meeting
Room Potsdam
2100–2230
DGA-Vorstandssitzung
Room Berlin
Thursday, 29 November 2012
1045–1300
ESAU Board Meeting
Room Berlin
1130–1330
EAA Ultrasonography Meeting
Room Harvard
1845–1945
EAA General Assembly
Room Berlin
Friday, 30 November 2012
0915–1215
EAA Education Committee Meeting
Room Berlin
1100–1500
Meeting of the Infertility Guideline Group of the EAU
Room Potsdam
1245–1445
Treffen des Arbeitskreises Andrologie der DGU
Room Berlin 1830–1930
Room Stanford
54
Mitgliederversammlung der DGA
Lift
Lift
Poster
Area
1
2
3
4
5
7
8
6
9
10
11
12
14
13
Industrial Exhibition
Check-In
Catering
Plan of Exhibition Area
State at printing
55
Sponsors and Exhibitors
We would like to thank the following companies for their kind support:
Bronze Sponsor
MEDA Pharma GmbH & Co. KG (Bad Homburg/DE)
Other Sponsors
AMS Deutschland GmbH (Berlin/DE)
Farco-Pharma GmbH (Cologne/DE)
Fresenius Kabi Deutschland GmbH (Bad Homburg/DE)
Jenapharm GmbH & Co. KG (Jena/DE)
Lilly Deutschland GmbH (Bad Homburg/DE)
Exhibitors
AIR LIQUIDE Medical GmbH (Düsseldorf/DE)
AMS Deutschland GmbH (Berlin/DE)
BIOMED Labordiagnostik GmbH (Oberschleissheim/DE)
Deutsche Klinefelter-Syndrom Vereinigung e. V. (Ratingen/DE)
Farco-Pharma GmbH (Cologne/DE)
Fertikult Gück GmbH (Berlin/DE)
Glenwood GmbH (Starnberg/DE)
Jenapharm GmbH & Co. KG (Jena/DE)
Lilly Deutschland GmbH (Bad Homburg/DE)
Merck Serono GmbH (Darmstadt/DE)
MEDA Pharma GmbH & Co. KG (Bad Homburg/DE)
ORIGIO GmbH (Berlin/DE)
tic Medizintechnik GmbH & Co. KG (Dorsten/DE)
TransMIT–Fertisure (Gießen/DE)
2
1
4
12
14
3
10
8
9
7
6
5
11
13
Financial Support
Travel grants – International Society of Andrology (ISA) and European Academy of Andrology (EAA)
B. Braun-Foundation
German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)
56
State at printing
Media Cooperations
Biermann Verlag GmbH (Cologne/DE)
Urologische Nachrichten
Blackwell Verlag GmbH (Berlin/DE)
Journal der Deutschen Dermatologischen Gesellschaft
European Association of Urology (Arnheim/NL)
European Urology Today
Informa Healthcare (London/GB)
Scandinavian Journal of Urology and Nephrology • The Aging Male
Krause und Pachernegg GmbH (Gablitz/AT)
Journal für Reproduktionsmedizin und Endokrinologie • Journal für Urologie und
Urogynäkologie
Nature Publishing Group (Tokyo/JP)
Asian Journal of Andrology
OmniMed Verlagsgesellschaft mbH (Hamburg/DE)
DERM Praktische Dermatologie
Pro anima medizin medien OHG (Mülheim a. d. R./DE)
Andrologen.info – Zeitschrift für Urologie und Andrologie
S. Karger AG (Basel/CH)
Urologia Internationalis
Springer-Verlag France S.A.R.L.(Paris/FR)
Andrologie
Springer-Verlag GmbH (Heidelberg, Berlin/DE)
Hautnah Dermatologie • Uro News • Der Urologe
Thieme Publishers (New York, NY/US)
Seminars in Reproductive Medicine
Wiley-Blackwell (Oxford/GB)
Andrology
State at printing
57
lunch symposia*
friday, 30 november 2012
ANNA C-TRUS – artifizielle neuronale Netzwerk-Analyse
fresenius Kabi Deutschland GmbH (bad Homburg/De)
Saturday, 1 December 2012
Hypogonadismus – aktuelle Aspekte aus Klinik und Forschung
Jenapharm gmbH & Co. Kg (Jena/DE)
* Please note: The symposia will be held in german language.
58
FREE ACCESS to recent
articles covering all aspects
of male health from
ThE Aging MAlE
2011
impact
Factor:
1.518*
Simply scan the QR code to access your FREE articles
or visit informahealthcare.com/ECA_2012
*© Thomson Reuters Journal Citation Reports® 2012
Social and Cultural Programme
Welcome Reception
The welcome reception will take place following the first sessions of the
conference on Wednesday, 28 November in the foyer of the conference
venue. Everyone is invited to come together for snacks and drinks
after the conference’s kick-off to meet and greet with colleagues and
exhibitors.
Date
28 November 2012
Begin
1900
PlaceFoyer of the conference center
FeeFree of charge
Conference Dinner
The restaurant “Nolle” is located in the heart of Berlin, directly under
the historic S train arch (S- and U-Bahnhof Friedrichstraße) and offers
an impressive original atmosphere of a typical 1920´s restaurant, giving
a perfect ambience for our Berlin dinner. “Nolle” is where the first beer
palace, “Der Franziskaner”, was opened a hundred years ago. It is a place
of traditional hospitality, showing Berlin as it was in the past and as it
continues to be in the present.
© Farina3000 • Fotolia.com
© Restaurant Nolle Berlin
Join us for a unique evening, only a few steps away from the most famous sightseeings of Berlin: The
“Fernsehturm” (Television Tower) and “Alexanderplatz” to your left, “Brandenburger Tor“ and “Reichstag” (German Parliament) to your right.
© Restaurant Nolle Berlin
Date
29 November 2012
Begin
2015
PlaceRestaurant Nolle
FeeEUR 45
AddressRestaurant Nolle
Georgenstraße/S-Bahnbogen 203
10117 Berlin
60
Social and Cultural Programme
Berlin at Night
Join an individual city tour of a special kind. Enjoy the highlights of
Berlin within a two hour guided tour after sunset.
A city guide will show famous and maybe less known sights of Berlin,
accompanied by humorous moderation.
Date
29 November 2012
Begin/duration
1800/approx. 2 hrs
FeeEUR 12
Meeting point Potsdamer Platz (green old traffic lights)*
© Marcus Klepper• Fotolia.com
The Historic Center of Berlin – Part I
Follow the history of Berlin and experience the past and present of
Germany’s capital city. The city tour starts at “Alexanderplatz” and leads
to “Museumsinsel”, Berlin Cathedral and “Brandenburger Tor”, just to
name a few.
Date
29 November 2012
Begin/duration
1100/approx. 2 hrs
FeeEUR 12
Meeting point
“Weltzeituhr” (World time clock) at Berlin
Alexanderplatz*
© Sliver • Fotolia.com
The Historic Center of Berlin – Part II
Walking by the relics of the Berlin Wall – this historic guided city tour
starts at “Checkpoint Charlie” and follows the former course of the “Wall”
until “Potsdamer Platz”. After a stop at the “Holocaust Memorial”, this
tour will continue to “Brandenburger Tor” and “Pariser Platz”.
Date
30 November 2012
Begin/duration
1300/approx. 2 hrs
© fotoman_65 • Fotolia.com
FeeEUR 12
Meeting point
Checkpoint Charlie underneath the sign
marking
“Sie verlassen den amerikanischen Sektor”
(You are leaving the American sector)*
* Please note that guided tours will start in the city centre and consider additional time for the subway ride from Dahlem to
Berlin Centre (about 30–45 min)
61
Social and Cultural Programme
Suggestions for individual sightseeing
Berlin-City-Tour with a double-decker bus
The city tour with the Berlin double-decker bus starts daily at 1000 every 15 and
20 min on a defined route and takes approximately 2.5 hours. You can hop on
and off at any bus stop you prefer. The main bus stops are “Kurfürstendamm”,
“Potsdamer Platz”, “Berlin Central Station”, “Unter den Linden” and “Alexanderplatz”. A guide will join you to tell details about the sights in German and English.
Time
every 15–20 minutes (daily from 1000)
Fee approx. EUR 15
© spuno • Fotolia.com
Berliner Fernsehturm (Television Tower)
With 368 m height, the tower is the highest accessible building throughout Europe
and an emblem of Berlin. It is a must for every trip to Berlin!
Time
1000–2400
AddressAlexanderplatz • 10178 Berlin (Mitte)
Fee
approx. EUR 12
Jüdisches Museum (Jewish Museum)
The Jewish Museum in Berlin is the biggest museum in Europe of its kind and
shows the German-Jewish history of two centuries. The zig-zag pattern of the
building symbolizes a bursting Star of David.
Time
1000–2000
AddressLindenstraße 9–14 • 10969 Berlin (Kreuzberg)
Fee
approx. EUR 5
Zeughaus
It is the oldest maintained building at the Boulevard “Unter den Linden“ and a
famous baroque construction at the same time. It was built to be an armory, but
since 2006 it belongs to the German Historic Museum (Deutsches Historisches
Museum). The permanent display is very popular and is supported by variable
special displays.
Time
1000–1800
Address
Unter den Linden 2 • 10117 Berlin (Mitte)
Fee
approx. EUR 5
Museumsinsel (Museum Island)
On an island in the river “Spree”, directly in the city centre of Berlin, you will find
the most impressive museum complex of Europe – the “Museumsinsel” is part
of the UNESCO world heritage since 1999, hosting six museums with different
kinds of displays and collections.
AddressBodestraße 1–3 • 10178 Berlin (Mitte)
Time
1000–1800
Fee
approx. EUR 14–19
62
© Goecko • Fotolia.com
© paul prescott• Fotolia.com
© ProgRock • Fotolia.com
© Katja Xenikis• Fotolia.com
General Information
Venue
Seminaris CampusHotel Berlin
Science & Conference Center
Takustraße 39 • 14195 Berlin (DE)
Date
28 November–1 December 2012
Homepage
You will find current information on our website www.andrology2012.de.
Registration
Please register online at www.andrology2012.de. For registrations via fax or postal mail, please use the
registration form in the middle of this brochure.
Conference Fees
Non-member
Member ESU/EAA/ESAU/DGA*
Student/Postgraduate/Medical Assistant*
Two-day ticket (30 November + 1 December)
Conference Dinner (29 November)
EUR 450
EUR 390
EUR 170
EUR 270
EUR 45
* Please provide confirmation.
Payment/Confirmation of Payment
An invoice or confirmation of registration will be sent to you via postal or electronic mail within 14 days
after online or paper registration. This invoice is a valid invoice which may be submitted to the local tax
and revenue office. All fees are due upon receipt of invoice/registration confirmation. Payment transfers
must include participant’s name and invoice number. Payment is also accepted by credit card (Master-/
Eurocard, American Express, VISA). Should you transfer your invoice amount within 10 days of the
start of the event, please present your transfer remittance slip at the check-in desk as proof of payment.
Hotel Reservation/Accommodation
We have allocated a contingent of rooms at special rates at the hotels listed on the congress homepage
www.andrology2012.de.
Please note: Conventus GmbH acts as an intermediary party and assumes no liability for reservations
made. Changes and cancellations have to be addressed to the appropriate hotel directly.
63
General Information
Arrival/Parking
By car
Address for Navigation Systems
Seminaris CampusHotel Berlin • Science & Conference Center
Takustraße 39 • 14195 Berlin (DE)
© Seminaris CampusHotel Berlin
Parking
Parking is available in the underground car park directly underneath the Seminaris CampusHotel and at
the museum just next to it.
By Plane
The closest airport to the venue is Berlin-Tegel. It is a 20 min cab ride to the venue. You may also take the
public transportation. Please take the bus 109 or X9 towards “Zoologischer Garten“ and switch into the
underground station into U7 towards „Rudow“. Please change trains at „Fehrbelliner Platz“ into U3 towards
„Krumme Lanke“. Please exit at “Dahlem-Dorf”. From here it is only 500 m to the Seminaris CampusHotel.
By Train
The easiest way is to arrive directly at the main train station in the city center of Berlin. From here, please
use the public transportation:
Take S 5 to “Spandau” or S 7 to “Potsdam Hauptbahnhof” and switch trains at “Westend” into S 41 or S 42
towards “Ostkreuz”. Switch trains again at “Heidelberger Platz” into U 3 towards “Krumme Lanke”. Please
exit at “Dahlem-Dorf”. From here it is only 500 m to the Seminaris CampusHotel.
Environmental Badge
The environmental badge is obligatory for the green zone in Berlin, also for foreigners! Vehicles with no
environmental badge may not pass through the green zone, otherwise there will be a penalty of EUR 40
and a penalty point in penal record Flensburg impend, even if the vehicle would be allowed to pass through
the zone based on its emission value. This is also valid for all vehicles registered in foreign countries, like
cars, trucks and busses, as well as for business travellers and for tourists.
64
General Information
Cooperation with German Railways
Good for environment. Convenient for you. Travel by train from Euro 99 to
the 7th European Congress of Andrology 2012.
With the offer of Conventus Congressmanagement & Marketing GmbH and
German Railways you can save money by visiting the 7th European Congress of
Andrology 2012! Get on board and profit from attractive prices and conditions
for train travel.
Have a good connection to your venue and to the nature! Compared with a car
each journey by train spares the environment two-thirds CO2 and compared
with a plane even respectable 75 percent.
The ticket price to and from Berlin accounts:
travelling nationwide, from every train station with the possibility of reservations for a specific train*
• National price for ticket with train connection (available daily):
− 1st class EUR 159
− 2nd class EUR 99
• National price for open ticket (available Mo–Th only):
− 1st class EUR 189
− 2nd class EUR 129
This special offer is valid for all congresses of Conventus Congressmanagement & Marketing GmbH in 2012.
Your ticket is valid from 26 November–3 December 2012.
Please call our service number +49 (0)1805 31 11 53** to book your ticket and quote Conventus as reference.
Have your credit card ready please.
Your price advantages compared to the regular price in the 2nd class***:
From ↔ to (and return)
Dresden
Munich
Cologne
Hamburg
↔
↔
↔
↔
Berlin
Berlin
Berlin
Berlin
Regular fair
Offer to ECA 2012
Savings
EUR 270
EUR 256
EUR 226
EUR 146
EUR 99
EUR 99
EUR 99
EUR 99
EUR 171
EUR 157
EUR 127
EUR 47
We wish you a pleasant journey with German Railways!
* Changes and reimbursement before the first day of validity are EUR 15 excluded from the first day of validity onwards.
Passengers restrict themselves to a particular train and travel times. For a supplement of EUR 30 in 2nd class resp. EUR 20
in 1st class full flexible tickets are also available.
** The booking line is available from Monday to Saturday 0800–2100 o´clock. Calls will be charged at EUR 0.14 per minute, the
expenses from cell phones max. EUR 0.42 per minute.
***Prices are subject to change.
65
General Information
Check-in
The check-in is located in the entrance area of the conference center.
Education Credits and Certification
The 7th European Congress of Andrology will be certified by the Berlin Chamber of Physicians (Ärztekammer Berlin) with 21 CME points category B and at the Academy of German Urologists (Akademie
der Deutschen Urologen).
Scientific Programme
28 November 2012
29 November 2012
30 November 2012
1 December 2012
Category B Category B Category B Category B 3 Points
6 Points
6 Points
6 Points
All attendants are required to sign the certification list near the check-in daily for certification. Certificates of attendance may be picked up upon leaving the congress at check-in.
ESU Courses
Courses on Operative Andrology will be accredited by the European Union of Medical Specialists (Union
Européenne des Médecins Spécialistes – UEMS) with 2 credit points per course.
List of Attendants
Please remember to sign the list of attendants (with barcode, if required or applicable) which is available
at the check-in.
Certificate of Attendance
Certificates of attendance are available on the last day of the congress at the check-in.
Name Tag
Attendants will receive a name tag after registration. Admittance to the congress and industrial
exhibition is only allowed for those with a name tag. Name tags should be worn at all times. Name tags
for exhibitors will be given to the exhibit personnel.
Evaluation
Please turn in your completed and legible evaluation form to the check-in on the last day. We are always
striving to provide high congress quality. This goal can only be reached with your help, your active
participation and constructive criticism.
66
General Information
Wardrobe
The wardrobe is situated in the foyer and is free of charge.
Speakers Preview Area
The speakers preview area is placed in the foyer.
Industrial Exhibition
There is an accompanying industrial exhibition. The exhibitors are looking forward to welcoming you
and to present their comprehensive range of innovative products. For a detailed layout of the exhibition
plan see page 55.
Opening Hours
Industrial Exhibition
Check-In
Speakers Preview Area
Wednesday
28 November
1530–2030
1500–1930
1500–1930
ThursdayFridaySaturday
29 November
30 November
1 December
0830–1900
0800–1900
0800–1345
0800–1930
0800–1900
0800–1600
0800–1715
0800–1715
0800–1330
Internet
WLAN is accessible at the venue. For further information, please ask at the check-in. Furthermore, there
are computers with internet access available at the speakers preview area.
Language
The official congress language is English.
Note: The Annual Meeting of the German Society of Andrology (DGA) will be held in German.
Abstract Volume
Abstracts will be published in the “Journal für Reproduktionsmedizin und Endokrinologie (JRE)” which
will be handed out on site.
Catering
Catering will be provided during the official programme breaks in the industrial exhibition at the points
marked “Catering” (see page 55).
Smoking
Smoking is prohibited inside the conference center.
Restrooms
Please follow signs or ask at check-in.
67
General Information
Service for Handicapped Persons
The premises are suitable for the handicapped.
Event and Presentation Types
Scientific Lectures
In a scientific lecture, empirical work, theoretical or methodological developments, including own
scientific position are shown on the subject.
Poster Sessions
Abstract authors will have the opportunity to present their posters briefly during guided poster sessions.
Annual Meeting of the DGA
The German Society of Andrology (DGA) represents the interests of everyone involved in andrology and
aims to support, strengthen and develop the fields in research and clinical application.
Please note that the annual meeting will be held in German language.
ESU Courses
The European School of Urology (ESU) belongs to the European Association of Urology (EAU), which
represents the leading authority within Europe on urological practice, research and education. These
courses make sure that participants receive top-quality, clinically-oriented information, which can be
used in clinical practice.
Please book in advance. A separate fee incurs.
© www.uroweb.org
INYR Session
The International Network for Young Researchers in Male Fertility (INYR) assists young scientists in
testis research in achieving their highest potential as a researcher, and to stimulate high quality. It is
committed to establishing global networks between young (early stage) scientists in testicular research
and to promote cooperation and mutual exchange of methodologies and expertise.
© www.youngresearch.eu
68
Instructions for Speakers and Poster Presenters
Submitting your Presentation/Technical Information
Please prepare your presentation in 4:3 aspect ratio.
A presentation notebook with a PDF reader and MS Office PowerPoint 2010/2007 will be provided.
The use of personal notebooks is possible upon agreement. However, it may interrupt the flow of the
programme in the lecture hall.
A notebook, presenter and laserpointer are available at the speaker’s podium in the lecture hall.
A technical supervisor can help you.
Presentation Times
Short oral presentations (Wednesday)
Selected free presentations at ECA sessions
ESU course short oral presentations
7 + 3 minutes
12 + 3 minutes
7 + 3 minutes
Chairs may interrupt should you overrun your time limit.
Please note: Certain encodings for video and audio files could lead to problems. Please visit our speakers
preview area.
Should you wish to use non-digital equipment, please contact us ([email protected]).
For further information please visit www.andrology2012.de.
Speakers Preview Area
The speakers preview area is located in the foyer of the conference center. Please follow the signage
on-site or ask at the check-in.
Please submit your presentation at the speakers preview area on the day before your presentation, but
no later than 2 hours before the presentation should begin. You may view and/or edit your presentation.
For submission, please use a USB flash drive, CD or DVD disc and do not protect it with software.
Speaking Time
Please prepare your presentation for the allotted amount of time. Chairs and moderators may interrupt
should you overrun your time limit.
Poster Sessions
Posters should be no larger than DIN A0 (84.1 cm x 118.9 cm). Poster pinboards are 120 cm x 150 cm.
They are only to be used with the designated pins. Pinboards will be numbered. You will find your
poster number in the programme book on pages 34–53.
Posters should be hanging on Wednesday, 28 November, 2012 until 1600 and should be removed by Friday,
30 November, 2012 until 1830. Posters with even numbers will be presented on Thursday, 29 November,
2012 from 1015 to 1115, posters with odd numbers from 1115 to 1215. Poster presenters are asked to be
present during the poster sessions.
69
Index of Authors and Chairs
A
Abarikwu, S.
Abdul Rahim, A. F.
Abdul Rahman, S.
Abdul Wahab, A. Y.
Abdulhak, A.
Adami, H.-O. Adamopoulos, D. A.
Adorini, L.
Ågren Silfver, K.
Akaf’eva, T. I. Akhondi, M. M.
Albert, M.
Alchinbayev, M.
Alesse, E.
Alif, S.
Allam, J.-P.
Almeida, M.
Almstrup, K.
Altinkilic, B.
Alves, M.
Amaral, A.
Amini, M.
Amirjanati, N.
Amorim, R.
Anand-Ivell, R.
Andersen, J. M.
Anderson, R.
Andersson, A.-M.
Andreassen, K. E.
Andreja, K.
Ansari, A. S.
Antignac, J.-P.
Arda, O.
Arnold, G. J.
Ars, E.
Aschim, E.
Aslani, F.
Atanassova, N.
Aulitzky, W.
Ausmees, K.
Axelsson, J.
Aziz, A.
70
42
40
38
38, 40
19, 38
48
20
49
42
43
46, 47, 51
39
19
51
40
34, 38
48
26, 46
34, 43
37
27, 40
35
47
25, 28, 51
12, 28
50
43
40
48
47
16
40
51
46
44, 45
48
24
42
27
14, 47
42
38
B
Baal, N.
45
Bahadori, M. H.
44
Baharudin, N.
38
Bailly, M.
39
Bak, C.
23, 47
Baldi, E.
23, 39, 46, 47, 50
Balercia, G.
49, 50, 53
Balla, M.
16
Ballauf, K.-G.
51
Balzi, D.
52
Bandini, E.
49, 52
Bang, A. K.
50
Baranowska-Bosiacka, I.
42
Barbonetti, A. 24, 35, 39, 40, 52
Barbosa da Costa Gomes, P. 46
Barros, A.
37
Bartfay, G.
52
Bassas, L.
44
Bassett, S.
35
Bauer, H.
45
Behre, H. M.
13, 33, 38, 39
46, 47
Bentmar Holgersson, M.
44
Bergere, M.
39
Bergmann, M. 30, 35, 36, 37, 43
Beschmann, H.
40
Bettocchi, C.
18, 22
Bhushan, S.
34, 35
Biarda, B.
45
Bilińska, B.
36
Bizzaro, D.
43
Bliznetz , E.
43
Blum, H.
44
Bobjer, J.
14
Boddi, V.
50
Bödeker, R.-H.
34
Boitani, C. 16
Boitrelle, F.
39
Bongers, R.
45
Bongers, R.
45
Boonen, S.
52
Borgers, M.
37
Bouic, P.
48
Bozzini, G.
22, 26
Braga, I.
47
Breda, Š.
47
Brehm, R.
36
Bremnes, R. M.
48
Brizhatyuk, E.
35, 52
Bröcher, A.-L. 44
Brokken, L. J. 43
Brookman-May, S.
38
Brycz-Witkowska, J.
45
Brys, M.
36
Budna, E.
45
Buividaite, M.
36
Bujan, L.
42
Burkhardt de Koivisto, M. 46
Bustos Obregon, J. E.
21, 40
Bykova, L.
34
Byun, J. S.
47
C
Cadet, R.
Calarrao, A.
Calcagno, A.
Camarena, S.
Cambi, M.
Cappallo-Obermann, H.
Carini, M.
Carrell, D. T.
Casale, H.
Casanueva, F.
Castiglioni, M.
Castiglioni, F. M.
Castillo, J.
Cavaco, J. E.
Cavaco, E. B.
Cellai, I.
Cellini, N.
Cenci, T.
Chakraborty, T.
Channer, K.
Charron, Y.
38
43
49
16, 35
39
23, 39
47
21
52
52
28, 39
28, 39
21
37
37
49, 50
51
47
34, 35
18
45
Index of Authors and Chairs
Chatzikyriakidou, A.
45
Chen, T.
35
Chernykh, V.
43
Chianese, C.
27, 45
Chojnacka, K.
36
Chukhrova, A.
43
Ciechanowski, K.
37
Colpi, G. M.
25, 39
Comeglio, P.
49, 50
Conceição, P.
47
Conrad, M.
38
Cordeschi, G.
38, 39
Corona, G.
13, 23, 42, 46
49, 50, 52, 53
Cox, K.
38
D
Daguin, F.
45
Dahl, O.
48
vom Dahl, J.
31
Damon-Soubeyrand, C.
38
D’Andrea, S.
38
D’Angeli, A.
38
Danielyan, T.
34
De Gendt, K.
42
Dean, A.
42
Degli Innocenti, S.
46
Dias, J.
19, 51
Diemer, T.
22, 26, 30, 33
34, 35, 38, 43
Dimitriadis, F.
45, 50
Discher, T.
34
Dmitrishin, A.
34
Dohle, G.
22, 25, 27, 33, 47
Donat, R.
47
Dreier, K.
38
Drevet, J.
38
van den Driesche, S. 16, 42, 43
Duchnik, E.
42
E
Egeberg, D. L.
46 Francavilla, F.
24, 35, 38, 39
40, 51
Ehala-Aleksejev, K.
42, 49 Francavilla, S.
23, 35, 38, 39
Ehmcke, J.
37, 42 40, 51
Eichner, G.
37 Frederiksen, H.
40
Eisenberg, M. L.
21, 25 Freitas, R.
51
Ellis, D.
34 Fröhlich, T.
46
Elteer, B.
22 Fusco, F.
20
Elzinga-Tinke, J.
47
Erasmus, N.
35 G
Erenpreiss, J.
36 Gacci, M.
49, 50
Escórcio de Almeida, F. A. 48 Gaczarzewicz, D.
36, 44
Espiridião, P.
51 Galuska, S. P.
12
Gamidov, S.
20, 49, 51
F
Garten, A.
46
Faravelli, C.
49 Gatimel, N.
16, 38
Farombi, E.
42 Georgiou, I.
45
Ferens-Sieczkowska, M. 42, 43 Giachini, C.
45
Ferfouri, F.
27, 39 Giebler, M.
38, 39
Ferraz, L.
51 Gill, K.
44
Festa, R.
51 Giornetta, A. C.
35
Feuerstacke, C.
37 Di Girolamo, E.
38
Fietz, D. 12, 36 Giwercman, A. 18, 42, 43, 44, 52
Fijak, M.
35, 45 Glensbjerg, M.
46
Filimberti, E.
46 Godinho, R.
47
Filippi, S.
49, 50 Godovalov, A.
34
Filipponi, S.
51 Gokhale, R.
34
Finn, J.
52 Goulis, D.
13
Fino, M. G.
46 Grande, G.
47
Fisher, A. D.
53 Grandjean, P.
44
Fisher, D.
34, 53 Greither, T.
38, 39, 46, 47
Fiutek, R.
42 Gromoll, J.
24, 37, 45
Flenkenthaler, F.
46 Grotmol, T.
48
Fontenot, G.
48 Grunewald, S.
33, 46
Forma, E.
36 Grzegrzółka, A.
42
Fornara, P.
46 Gudipati, M.
40
Forti, G.
24, 39, 42, 45 Gulino, G.
47
46, 47, 49, 50, 52, 53 Günther, S.
36
Fortuin, K.
35 Gutermuth, J.
20
Fosså, S.
48 Gutschi , T.
38
Fraczek, M.
14, 44 Gwak, J. H.
47
Fraga, A.
47, 48
71
Index of Authors and Chairs
H
Hackstein, H.
35, 38
Haggeney, T.
35
Haider, A.
13, 45, 48
Haidl, G.
29, 33, 38
Hakenberg, O. W.
51
Hamdi, S.
12
Han, T.
52
Hansen, C.
46
Haugen, T. B.
26, 48, 50
Hauptmann, A.
38
Heidari-Vala, H.
46
Hejmej, A.
36
Hemingway, V.
40
Henkel, R.
16, 21, 34, 35, 48
Hentrich, A.
37
Herning, H.
50
Herrmann, B. G.
45
Hickerton, B.
34
Hjelmesæth, J.
50
Hoffmann, I.
38, 39
Howard, G.
47
Hudemann, C.
34
Huhtaniemi, I. T.
20
Hüppe, P.
45
Huyghe, E.
42
I
Ibishev, K.
Irez, T.
Irrle, S.
Isidori, A. M.
Isus, F.
J
Jacobeit, J. W.
Jakop, U.
Janjgava, S.
Jannini, E. A. Jensen, T. K.
Jezek, D.
Joaquim, S.
Joensen, U.
72
34
51
26
14
42
32
39
13
14, 52
21
51
44
40
Jönsson, B. A.
43
Jørgensen, N. 40, 42, 46, 48, 50
Jožko, O.
47
Jungwirth, A.
22, 24, 27
Juul, A.
24, 50
K
Kadioglu, A.
20
Kakies, C.
51
Kałuża, A.
42
Kamaletdinov, N.
51
Kampschulte, M.
43
Karlsson, R.
48
Kazienko, A.
44
Kedzierska, K.
37
Kelnar, C.
43
Kerr, G.
47
Kholtobin, D.
35, 52
Kiess, W.
46
Kilcoyne, K.
42
Kipper, B.
46
Kirchhoff, C.
36
Kistler, V.
38
Kjærulff, S.
46
Klepp, O.
48
Kliesch, S.
30, 32, 37, 44, 45
Klug, J.
5
Kluge, P.
45
Kocer, A.
38
Kocvara, R.
22
Koelle, S.
28
Kogan, M.
34
Köhn, F.-M.
30, 32
Kolasa, A.
42
Kolbezen, M.
40
Kold Jensen, T.
21, 44, 49
Kondarewicz, A.
42
Konrad, L.
37
Kopa, Z.
25, 26
von Kopylow, K.
36
Korrovits, P.
47
Koruji, M.
35
Kossack, N. M.
42
Kostadinovic, H.
40
Kotula-Balak, M.
36
Koukos, S. 50
Kowalska-Olejnik, B.
42
Kozina, V.
51
Koziol, K.
45
Kratz, E. M.
42, 43
Kratzsch , J.
46
Kraus, M.
47
Krause, W.
32
Krausz, C. G.
27, 43
Kristiansen, W.
48
Krombach, G.
43
Kruger, T.
34
Kula, K.
12, 36, 37, 52
Kulchavenya, E.
14, 35, 52
Kurilo, L.
43
Kurpisz, M.
24, 44
Kurzawa, R.
44
Kvist, L.
44
L
La Barbera, A.
Labanaris, A.
LaFuente Carvalho, J.
Lakpour, N.
Lanciotto, M.
Lang, T.
Langberg, C. W.
Langenstroth, D.
Langheinrich, A.
Larocca, L. M.
Laszczynska, M.
Le Bizec, B.
Lean, M.
Leandri, R. D.
Lebedinskaya, O. V.
Lee, D.
Leiber, C.
Leisegang, K.
Lenzi, A.
50
38
48
46, 51
47
14, 34
48
37
43
47
37
40
52
38
43
52
30, 31
13, 48
50
Index of Authors and Chairs
Lepadatu, C.
Lewandowski, P.
Li, H.
Lindgren, I.
Linn, T.
Liu, N.
Lo Giacco, D. G.
Lohmeyer, M.
Lohmeyer, J.
Lombardelli, L.
Looijenga, L.
Lotti, F.
Louro, N.
Lu, Y.
Ludwicki, J. K.
Lundberg Giwercman, Y.
Luzi, S.
Lydka, M.
Lyu, S. W.
39
45
12
44
43
35
44, 45
43
34, 43
49
26, 47
14, 46
47, 48
35
43
43, 44
51
36
47
M
Macpherson, S.
42
Maggi, M.
18, 39, 42, 46
49, 50, 52, 53
Mahmoudi, A. R.
46
Mahmoudian, J.
46
Makhmudov, R. R. 43
Mala, T.
50
Maliske, J.
29
Mallidis, C.
23
Mamoulakis, C.
45
Mancina, R.
50
Mancini, A.
51
Mändar, R.
47
Maneschi, E.
49, 50
Manicardi, G.-C.
43
Mannucci, E. 42, 49, 50, 52, 53
Mantini, G.
51
Marchiani, S.
39, 46, 47, 50
Marchlewicz, M.
42
Marchlewska, K.
36, 37
Marconi, M.
24, 26, 27, 35
Marcou, M.
46
Marija, P.
47
De Marinis, L.
47
Martini, M.
47
Martins, A. D.
37
Maseroli, E.
49, 53
Massat, G.
42
Mata, A.
16
Matomäki, J.
42
Mattiucci, G. C.
51
Mayerhofer, A.
46
Mazzanti, B.
49
McEleny, K.
40
McKinnell, C.
43
Md Isa, M. L. 38
Meinhardt , A.
12, 28, 33
34, 35, 45
Meißner, A.
29
Melani, C.
52
Mello, T.
49
Menné, T.
40
Meuleman, E. J. H.
18
Meyfour, A.
51
Meyron-Holtz, E.
12
Micillo, A.
38
Middendorff, R.
35, 37, 43
Mietens, A.
37
Mieusset, R.
42
Milardi, D.
47
Miller, D.
21
Minhas, S.
24, 26
Mirone, V.
18
Mitchell, R.
40, 43
Moeini, A.
19
Mohamad Al-Ali, B.
38
Mohd Arifin, N.
40
Mohd Bustaman, S. K.
40
Mohd Yatim, H.
40
Monami, M.
42, 49, 52
Morelli, A.
49, 50
Morikawa, Y.
29
Mösinger, C.
39
Müller, H.
Mühlfeld, C.
Müller, D.
Müller, L.
Müller, K.
Mullooley, C.
Mupfiga, C.
Muratori, M.
Musa, R.
De Mutis, A.
51
43
37
39
39
34
34
39, 46
40
35, 39
N
Nalazek, N. Natali, I.
Nef, S.
Nesi, G.
Neururer, S.
Nieschlag, E.
Nimptsch, A.
Noblanc, A.
Noci, I.
Nordkap, L.
Nosi, D.
Nowak, L.
de Nunzio, C.
38
39
28
47, 49
38
32
39
38
39
49
39
40
49
O
Ochsendorf, F.
O’Connor, D.
Oduwole, O. O.
Oliveira, P. F.
Oltermann, I.
O’Neill, T.
Ortiz, G.
Osadchiy, A.
Oszukowska, E.
Ovchinnikov, R.
14, 29, 40
52
21
37
38
52
35
52
36, 37
49, 51
73
Index of Authors and Chairs
P
Paasch, U.
39, 46
Di Padova, M.
51
Paiva, C.
40
Palanisamy, D.
28
Palminteri, E.
19
Pant, A.
42
Paradowska-Dogan, A. 16, 43
Parinaud, J.
38
Parr, N.
34
Paulus, P.
40
Pearce, S.
40
Pedersen, H. S.
43
Pelka, S.
46
Pelliccione, F.
22
Peltier, M.
38
Pendleton, N.
52
Peralta, J. P.
47
Perheentupa, A.
42
Petersen, J. H.
46
Petit, J.-M.
39
Pezzella, A.
25, 38
Piasecka, M.
36, 37, 44
Piccinni, M.-P.
49
Pierconti, F.
47
Pilatz, A. 13, 30, 34, 35, 43, 45
Pinzani, P.
47
Pitteloud, N.
26
Piwowar, A.
43
Plante, P.
42
Podolski, J.
48
Polyakov, A.
43
Pomm, K.
42, 49
Pontecorvi, A.
47, 51
Popken, G.
30
Popova, A.
49, 51
Porst, H.
32
Pourkeramati, F.
47
Protzel, C.
51
Pummer, K.
38
Punab, M.
42, 47, 49, 52
Pyttel, S.
39
74
R
Rabaça, C.
47
Raimondo, S.
51
Rajmil, O.
35, 44
Rajpert-de Meyts, E.
26
Ralph, D. J.
18
Ramalho-Santos, J.
40
Ramsey, S.
47
Rastkhani, H.
44
Rastrelli, G.13, 42, 49, 50, 52, 53
Resende de Carvalho, I.
46
Reuter, K.
37
Ribeiro, S.
48
Ricca, V.
49, 52
Rignell-Hydbom, A.
42
Rizaldi, F.
40
Robaire, B.
20
Rodrigues, L. H.
46
Rofena, S.
39
Rohayem, J.
26
Rönkä, R.
42
Röpke, A.
44
Rosner, M.
48
Rossi, E.
45
Rousseaux, S.
21
Ruhayel, Y.
44
Ruiz, P.
44
Ruiz Castañé, E.
44, 45
Rurik, I.
14
Rusz, A.
34
Rylander, L.
42, 43
Rymaszewska, A.
44
Ryzhkova, O.
43
S
Saad, F.
Saboohi, S.
Sachdeva, K.
Sadeghi, M. R.
Sadighi Gilani, M. A.
Sadov, S.
Saenko, E. V. Saez, F.
45, 48
44
43, 51
46, 51
27
42
43
38
Saito, M.
50
Salehi, Z.
44
Salonia, A.
18
Salvianti, F.
47
Sanchez, V.
16
Sandbu, R.
50
Santi, R.
49
Sarchielli, E.
50
Sarode, G.
44
Satoh, K. 50
Sauber, L.-J.
35
Saunders, P.
43
Schaab, M.
46
Schagdarsurengin, U.
44
Schegolev, A.
51
Schill, W.-B.
33
Schiller, J.
39
Schinzari, G.
47
Schlatt, S.
12, 29, 37, 42, 46
Schlößer, M.
38
Schneider-Hüther, I.
37
Schorle, H.
46
Schröder-Printzen, I.
31
Schuler, G.
35
Schultheiss, D.
31
Schulze, W.
30, 36, 39
Schuppe, H.-C. 23, 30, 34, 35, 43
Schwarzer, J. U.
25
Sciarretta, F.
39
Scognamiglio, V.
46
Seggewiss, J.
45
Selva, J.
39
Seok, H. H.
47
Sforza, A.
42, 49, 50, 52, 53
Shaeer, O.
14, 18, 36
Sharpe, R. M.
12, 42, 43
Shimizu, S.
50
Shiranov, K.
34
Silva, J.
37
Silva, C.
46
Silveri, A.
42
Simões, V. L.
37
Index of Authors and Chairs
Sismeiro, A.
47
Skakkebaek, N. E. 46, 21, 40, 42
Slowikowska-Hilczer, J. 24, 26,
36, 37
Sluczanowska-Glabowska, S. 37
Smith, L.
28, 42
Socorro, S.
37
Söder, O.
25
Sofikitis, N.
26, 45, 50
Sofras, F.
45
Sohn, M.
18, 20, 32
Sokolowska, M.
37
Solberg, A.
48
Solomon, M.
35
Soltanghoraee, H.
47
Sousa, M.
37
Spano, M.
43
Sperandio, A.
39
Sperling, H.
25, 30, 33
Spiess, A.-N.
36, 39
Sporniak-Tutak, K.
37
Staege, H.
36
Stammler, A.
37
Stanczak, H.
45
Steger, K. 16, 34, 44
Steinfatt, H.
20
Steinfeld, K.
43
Stenqvist, A.
42
Stewart, J.
40
Stötzel, S.
43
Strada, C.
49
Stukenborg, J. B.
27
Sulpizio, P.
39
Szypulska, D.
42
T
Tagliaferri, L.
Takenaka, A.
Tambi, M. I. Tamburrino, L.
Tarantin, A. V. Tasch, S.
51
50
35
39, 46, 47
43
37
Tauber, R.
22
Tazhetdinov, O.
49, 51
Tchatalbachev, S.
34, 35
Teramachi Trevisan, J.
46
Terwort, N.
37
Tesoriere, G.
39
Testa, P.
39
Teston , C.
25
Tewes, A.-C.
44
Theillac, C.
39
Thomas, S.
46
Thonneau, P.
42
Thyssen, J.
40
Timberg, G.
47
Toppari, J.
12, 25, 42
Torabi, F.
46
Torres Carreira, J.
46
Tournaye, H.
23
Tran, T. T. K.
42
Trottmann, M.
25, 33
Tsounapi, P.
50
Tubaro, A.
49
Tung, K.
24
Turek, P.
24
Tüttelmann, F.
12, 27, 31
32, 44, 45
U
Udodong, A.
48
Ulmer, H.
38
Urbschat, A.
40
V
Valentini, V.
51
Vanderschueren, D.
52
Vannelli, B.
49, 50
Vassallo, M. R. C.
35, 39, 40
Venturoli Perri, S. H.
46
Vettor, R.
49
Veyrand, B.
40
Vialard, F.
39
Vierula, M.
42
Vignozzi, L.
13, 46, 49, 50
Virtanen, H. E.
Vives Sune, A.
Vlachopoulou, E.
Volkmann, J.
42
35
45
37
W
Wabitsch, M.
47
Waclawska, A.
27
Wagenlehner, F.
24, 30
32, 34, 43
Wahle, E.
35
Wainer, R.
39
Walczak-Jedrzejowska, R. 36, 37
Walecki, M.
35, 45
Wallace, H.
43
Walschaerts, M.
42
Walz, J. C.
30
Wang, R.
35
Wehrend, A.
44
Weider, K.
36
Weidner, W.
12, 18, 20
28, 32, 33, 34, 35, 38, 43, 44
Weihe, P.
44
Welsch, U.
46
Welter, H.
13
Werler, S.
45
Wespes, E.
23
Westernströer, B.
37
Wetterauer, U.
32, 33
Weyand, I.
28
Wieacker, P.
44
Wiegratz, I.
40
Wiehle, R.
48
Wieland, W. F.
38
Wiklund, F.
48
Wilkie, A.
20
Will, H.
36
Windschüttl, S.
46
Wistuba, J.
24, 37, 45
Wiszniewska, B.
42
Witczak, O.
48, 50
Witt, J.
38
75
Index of Authors and Chairs
Woitzik, C. M.
Wolf, E.
Wolski, J. K.
Wolter, M.
Wu, F.
Wyllie, M.
20
44
45
37
18, 20, 52
23
X
Xambre, L.
51
Y
Yan, W.
Yang, Y.
Yaprak, E.
Yassin, A.
Yatsenko, A.
Yoon, T. K.
21
44
51
48
21
47
Z
Zainuddin, A. M.
Zaitseva, N. V. Zaki Shaeer, K.
Zarnani, A. H.
Zech, J.
Zemluanova, M. A. Zhang, Z.
Zhu, Y.
Zhukov, O.
Zigeuner, R.
Zimmer, M.
Zitzmann, M.
Zorn, B.
Zugor, V.
Zvezdin, V. N.
Zviezdai, V.
76
38, 40
43
36
46
38
43
34
35
18
38
42, 43
32, 33, 45
38, 40, 47
38
43
43
ABC
springer.com
Andrologie goes
international!
Andrologie
7 As of 2013 the
official journal of
the French Society
of Andrology will
be exclusively
published in English
7 Submit your
paper now!
Official Journal of the French Society
of Andrology (SALF)
Editor-in-Chief: R. Mieusset
The official journal of the French Society of Andrology - published
mainly in French until now - will become a fully international scientific
journal as of 2013. The multi-disciplinary journal will publish original
papers, review articles, case reports and educational articles in the
fields of basic and clinical andrology, making it of particular interest to
andrologists, urologists, endocrinologists, gynecologists, reproductive
biologists, and to all clinicians and scientists who are concerned with
male reproductive health.
Jump on board – submit your paper now!
Visit the journal’s homepage at springer.com/12610 and
7 read the most downloaded articles for free!
7 find detailed information on indexations and the editorial board
7 sign up for free Table of Contents Alerts
7 find instructions and information for authors
7 submit online
Easy Ways to Order (for the Americas) 7 Write: Springer Order Department, PO Box 2485, Secaucus, NJ 07096-2485, USA 7 Call: (toll free)
1-800-SPRINGER 7 Fax: +1(201)348-4505 7 Email: [email protected] or (for outside the Americas) 7 Write: Springer Customer
Service Center GmbH, Haberstrasse 7, 69126 Heidelberg, Germany 7 Call: +49 (0) 6221-345-4303 7 Fax: +49 (0) 6221-345-4229
7 Email: [email protected]
61677x
61678_Andrologie_148x210_4c.indd 1
10.07.12 12:19
General Terms and Conditions
Registration and Confirmation
Registration is subject to capacity limitations. Registration must include the name of any accompanying person to ensure
their inclusion into the planning of the social programme. Upon receipt of registration invoice or confirmation, registration
is considered official and effectual. This document is a valid VAT invoice which may be submitted to the local tax and revenue
office for tax purposes.
Invoicing and Due Date for Fees
Fees for the scientific programme of the event, the social evening and the social programme will be charged in the name and
on behalf of the company Conventus inclusive the statutory VAT rate of 19 % (as of 2010).
All fees are due upon receipt of the registration invoice or confirmation form. Transfer payments must include the name of the
participant and the invoice number, otherwise they will not be accepted. All major credit cards are accepted.
Scope of Services
Event fees and day tickets include participation in the scientific programme only. Additional fees for the ESU courses and social
programme will apply. Included in this fee are programme book, abstract book, name tags and a certificate of attendance. These
items are generally handed out at the venue.
Cancellations, Changes, Refunds
Cancellations can be made in written form only and will only be accepted if received by 28 October, 2012. A cancellation fee
of EUR 25 will apply. The same terms apply for cancellations of the social programme, however no cancellation fee will be
charged. Any cancellations after this date or no-shows at the event are not eligible for a refund and the full fee in accordance
to the registration invoice or confirmation will be due. Any changes in booking, after booking confirmation has been issued,
will result in a handling fee of EUR 15. Any requested additions to existing reservations or reservations made during the event
on-site will be processed according to availability. Event Cancellation, Refunds
There is limited capacity for all events. For certain events a minimum number of participants is required. If the minimum number
of participants is not reached, the organiser reserves the right to cancel all or parts of the event on a short-term notice. In this
case, all paid fees will be fully refunded.
Force Majeure, Disclaimer
The organiser is responsible for all changes to individual parts of the event. Claims for damages are excluded if the staging of
the event or individual components are hampered or prevented by unexpected political or economic events or generally by
force majeure or by the cancellation of speakers or if similar changes are required.
Hotel Reservations, Disclaimer
Conventus acts as an intermediary for hotel reservations and therefore assumes no liability for reservations. Changes and
cancellations have to be addressed to the according hotels directly. The cancellation terms of the individual hotels apply.
Limitation of Liability
Conventus acts as an intermediary for the programme offered by the organiser and, therefore, assumes no liability whatsoever
for the event. Any liability for services and possible problems with the services lies exclusively with the provider of services. Participation in activities of the social programme is exclusively at one’s own risk.
Conventus assumes liability for death or injury to body or health, provided there has been negligence or an intentional breach
of duties by the event organiser, its legal representatives, or vicarious agents.
In the event of any other damage, the liability of Conventus, its legal representatives and its vicarious agents is limited to deliberate and gross negligent conduct, provided that no essential contractual obligations have been breached.
Applicable Law, Place of Performance and Jurisdiction
The laws of the Federal Republic of Germany apply excluding the U.N. Convention on Contracts for the International Sale
of Goods (CISG). To the extent allowed by law, Jena is the place of performance and jurisdiction for all claims.
Use and Storage of Data
Information provided by you will be solely used for the purposes of contractual performance and/or the sending of event invitations from Conventus Congress Management & Marketing GmbH. Your information will not be provided to third parties unless
you have provided written consent. You have the right to request information at any time about your saved data without giving
reason. Information can also be edited, delete or blocked at any time. You may withdraw your consent to use your personal
information by contacting [email protected] or by postal mail at: Conventus Congressmanagement & Marketing
GmbH, Attn: Marketing, Carl-Pulfrich-Straße 1, 07745 Jena. Our online form is also available at www.conventus.de/mailing.
24 February 2012
78
FSS_01_En
nEw
The Farcosedan®-SET
For an almost aseptic and virtually pain-free prostate punch biopsy
 Farcosedan® and Endosgel® reduce the risk of infections from
exogenous and endogenous bacteria1
 Farcosedan® as the anaesthetic base contributes to a virtually
pain-free biopsy2
 The sterile applicator allows Farcosedan® to be placed specifically
in the rectum
 Because of the relatively high viscosity of Farcosedan®, the gel is
better able to remain in the rectum during biopsy
1
2
Skriapas K, et al. Urology. 2011 Apr; 77 (4): 905-8
Sperling H, et al. World J Urol 2002; 20:45-7
`